SRAX (SRAX) 10-Q 31 Oct 23 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Oct. 20, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-37916
Entity Registrant Name	SRAX, Inc.
Entity Central Index Key	0001538217
Entity Tax Identification Number	45-2925231
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1014 S. Westlake Blvd.
Entity Address, Address Line Two	Suite 14-29
Entity Address, City or Town	Westlake Village
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91361
City Area Code	323
Local Phone Number	205-6109
Title of 12(b) Security	Class A Common Stock, $0.001 par value
Trading Symbol	SRAX
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		29,438,762

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash	$ 116,000	$ 1,348,000
Accounts receivable, net	319,000	821,000
Contracts receivable	499,000	844,000
Marketable securities	2,918,000	15,617,000
Designated assets for return of capital	221,000	3,925,000
Prepaid expenses and other current assets	352,000	430,000
TOTAL CURRENT ASSETS	4,425,000	22,985,000
Marketable securities, net of current portion	18,203,000
Notes receivable		935,000
Property and equipment, net	121,000	114,000
Intangible assets, net		1,443,000
Right of use assets	162,000	257,000
Other assets	8,000	36,000
Goodwill	7,706,000	17,906,000
TOTAL ASSETS	30,625,000	43,676,000
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Accounts payable and accrued expenses	10,099,000	4,095,000
Deferred revenue	12,862,000	12,859,000
Other current liabilities	844,000	763,000
Payroll protection loan	10,000	10,000
OID convertible note(s) payable	1,094,000	1,164,000
Senior secured revolving credit facility, net of OID	5,478,000
Series A redeemable preferred stock	1,045,000	3,925,000
TOTAL CURRENT LIABILITIES	31,432,000	22,816,000
Right of use liability, net of current portion		114,000
TOTAL LIABILITIES	31,432,000	22,930,000
STOCKHOLDERS’ EQUITY (DEFICIT)
Series A preferred stock, $0.001 par value, 36,462,417 shares authorized, issued and outstanding, as liability classified at September 30, 2022 and December 31, 2021
Additional paid-in capital	52,643,000	51,075,000
Accumulated deficit	(53,476,000)	(30,355,000)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)	(807,000)	20,746,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY(DEFICIT)	30,625,000	43,676,000
Common Class A [Member]
STOCKHOLDERS’ EQUITY (DEFICIT)
Common Stock Value	26,000	26,000
Common Class B [Member]
STOCKHOLDERS’ EQUITY (DEFICIT)
Common Stock Value

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	36,462,417	36,462,417
Preferred stock, shares issued	36,462,417	36,462,417
Preferred stock, shares outstanding	36,462,417	36,462,417
Common Class A [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	26,355,951	25,995,172
Common stock, shares outstanding	26,355,951	25,995,172
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	9,000,000	9,000,000
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenues	$ 5,309,000	$ 6,888,000	$ 20,530,000	$ 18,963,000
Cost and expenses
Cost of revenues	942,000	3,354,000	9,181,000	8,541,000
Employee related costs	2,185,000	1,892,000	5,840,000	5,347,000
Selling, general and administrative	1,305,000	929,000	5,182,000	2,562,000
Depreciation and amortization	17,000	251,000	403,000	710,000
Total costs and expenses	4,449,000	6,426,000	20,606,000	17,160,000
Income (loss) from operations	860,000	462,000	(76,000)	1,803,000
Other income (expense)
Financing costs	(2,377,000)	(528,000)	(3,954,000)	(10,098,000)
Impairment of goodwill			(10,200,000)
Impairment of intangibles			(1,481,000)
Loss on sale of fixed assets			(47,000)
Realized gain (loss) on marketable securities	(286,000)	286,000	(6,521,000)	1,095,000
Current period change in fair value of marketable securities	(2,196,000)	(3,906,000)	1,696,000	(4,784,000)
Current period change in fair value of contract assets	22,000		(1,491,000)
Realized loss on designated assets	(904,000)	2,000	(1,803,000)	2,000
Current period change in fair value of designated assets	622,000	(134,000)	(710,000)	(134,000)
Change in fair value of preferred stock	281,000	134,000	2,513,000	134,000
Interest income		10,000	12,000	33,000
Other income (expense)	159,000	1,130,000	(1,058,000)	1,145,000
Total other expense, net	(4,679,000)	(3,006,000)	(23,044,000)	(12,607,000)
Income (loss) before income tax expense	(3,819,000)	(2,544,000)	(23,120,000)	(10,804,000)
Income tax expense
Income (loss) from continuing operations	(3,819,000)	(2,544,000)	(23,120,000)	(10,804,000)
Discontinued operations
Loss before income tax expense		(2,059,000)		(11,755,000)
Noncontrolling interest in discontinued operations		774,000		1,900,000
Income tax expense
Loss from discontinued operations		(1,285,000)		(9,855,000)
Net income (loss)	$ (3,819,000)	$ (3,829,000)	$ (23,120,000)	$ (20,659,000)
Basic and diluted income (loss) per share
Continuing operations, basic	$ (0.14)	$ (0.10)	$ (0.88)	$ (0.48)
Continuing operations, diluted	(0.14)	(0.10)	(0.88)	(0.48)
Discontinued operations, basic		(0.05)		(0.43)
Discontinued operations, diluted		(0.05)		(0.43)
Net income (loss) per share, basic	(0.14)	(0.15)	(0.88)	(0.91)
Net income (loss) per share, diluted	$ (0.14)	$ (0.15)	$ (0.88)	$ (0.91)
Weighted average shares outstanding, basic	26,341,615	25,019,645	26,207,696	22,707,446
Weighted average shares outstanding, diluted	26,341,615	25,019,645	26,207,696	22,707,446

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2020		$ 16,000	$ 69,551,000	$ (50,342,000)		$ 19,225,000
Balance, shares at Dec. 31, 2020		16,145,778
Share based compensation			253,000			253,000
Net Income (loss)				(11,090,000)	(854,000)	(11,944,000)
Shares issued for exercise of warrants		$ 5,000	12,215,000			12,220,000
Shares issued for exercise of warrants, shares		4,945,320
Shares issued for cash			284,000			284,000
Shares issued for cash, shares		53,616
Conversion of convertible debt to equity		$ 2,000	3,445,000			3,447,000
Conversion of convertible debt to equity, shares		2,041,551
Warrants issued as inducement to exercise warrants			7,737,000			7,737,000
Establishment of noncontrolling interest of FVPD					(95,000)	(95,000)
Warrants issued by FVPD for SRAX, Inc. debenture holders					885,000	885,000
Series B convertible preferred stock issued by FPVD					5,775,000	5,775,000
Beneficial conversion feature FPVD series B convertible preferred stock					5,775,000	5,775,000
Balance at Mar. 31, 2021		$ 23,000	93,485,000	(61,432,000)	11,486,000	43,562,000
Balance, shares at Mar. 31, 2021		23,186,265
Share based compensation			253,000			253,000
Net Income (loss)				(5,740,000)	(272,000)	(6,012,000)
Shares issued for exercise of warrants			3,575,000			3,575,000
Shares issued for exercise of warrants, shares		350,000
Conversion of convertible debt to equity			701,000			701,000
Series B convertible preferred stock issued by FPVD		1,000			85,000	86,000
Beneficial conversion feature FPVD series B convertible preferred stock					85,000	85,000
Series B convertible preferred stock issued by FPVD, shares		1,310,198
Balance at Jun. 30, 2021		$ 24,000	98,014,000	(67,172,000)	11,384,000	42,250,000
Balance, shares at Jun. 30, 2021		24,846,463
Share based compensation			251,000			251,000
Net Income (loss)				(3,829,000)	(774,000)	(4,603,000)
Shares issued for exercise of warrants			157,000			157,000
Shares issued for exercise of warrants, shares		53,668
Conversion of convertible debt to equity		$ 1,000	1,824,000			1,825,000
Conversion of convertible debt to equity, shares		730,616
Dividends on preferred stock			(6,387,000)			(6,387,000)
Balance at Sep. 30, 2021		$ 25,000	93,859,000	(71,001,000)	10,610,000	33,493,000
Balance, shares at Sep. 30, 2021		25,630,747
Balance at Dec. 31, 2021		$ 26,000	51,075,000	(30,355,000)		20,746,000
Balance, shares at Dec. 31, 2021		25,995,172
Share based compensation			358,000			358,000
Shares issued for exercise of employee options, net of taxes			(101,000)			(101,000)
Shares issued for exercise of employee options, net of taxes, shares		91,981
Net Income (loss)				3,728,000		3,728,000
Balance at Mar. 31, 2022		$ 26,000	51,332,000	(26,627,000)		24,731,000
Balance, shares at Mar. 31, 2022		26,087,153
Balance at Dec. 31, 2021		$ 26,000	51,075,000	(30,355,000)		$ 20,746,000
Balance, shares at Dec. 31, 2021		25,995,172
Shares issued for exercise of employee options, net of taxes, shares						427,667
Balance at Sep. 30, 2022		$ 26,000	52,643,000	(53,476,000)		$ (807,000)
Balance, shares at Sep. 30, 2022		26,355,951
Balance at Mar. 31, 2022		$ 26,000	51,332,000	(26,627,000)		24,731,000
Balance, shares at Mar. 31, 2022		26,087,153
Share based compensation			(870,000)			(870,000)
Net Income (loss)				(23,030,000)		(23,030,000)
Shares issued for exercise of warrants on a cashless basis
Shares issued for exercise of warrants on a cashless basis, shares		195,525
Shares issued for exercise of warrants			32,000			32,000
Shares issued for exercise of warrants, shares		8,401
Balance at Jun. 30, 2022		$ 26,000	50,494,000	(49,657,000)		863,000
Balance, shares at Jun. 30, 2022		26,291,079
Share based compensation			281,000			281,000
Net Income (loss)				(3,819,000)		(3,819,000)
Warrant modification expense			1,788,000			1,788,000
Shares issued for loan breakup fee			80,000			80,000
Shares issued for loan breakup fee, shares		33,000
Shares issued for exercise of employee options
Shares issued for exercise of employee options, net of taxes, shares		31,872
Balance at Sep. 30, 2022		$ 26,000	$ 52,643,000	$ (53,476,000)		$ (807,000)
Balance, shares at Sep. 30, 2022		26,355,951

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net loss	$ (23,120,000)	$ (20,659,000)
Less: net loss from discontinued operations, net of tax		9,855,000
Loss from continuing operations	(23,120,000)	(10,804,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of goodwill	10,200,000
Impairment of intangibles	1,481,000
Loss on sale of fixed assets	47,000
Realized gain (loss) on marketable securities	6,521,000	(1,095,000)
Current period change in fair value of marketable securities	(1,696,000)	4,784,000
Current period change in fair value of contract assets	1,491,000
Realized gain (loss) on designated assets	1,803,000	(2,000)
Current period change in fair value of designated assets	710,000	134,000
Change in fair value of preferred stock	(2,513,000)	(134,000)
Warrant modification expense	1,788,000
Stock based compensation (benefit)	(231,000)	757,000
Interest income		(33,000)
Amortization of debt discount	154,000	799,000
Loss on settlement of note receivable	35,000
Fair value of warrants issued by FPVD to SRAX, Inc. debenture holders		885,000
Forgiveness of payroll protection program loan		(1,116,000)
Warrant inducement expense		7,737,000
Net provision for (recovery of) bad debts	(60,000)	(305,000)
Depreciation expense	53,000	61,000
Amortization of intangibles	350,000	1,061,000
Amortization of right of use assets	95,000
Non-cash financing expense	237,000	213,000
Changes in operating assets and liabilities
Accounts receivable, net	563,000	1,537,000
Prepaid expenses and other current assets	105,000	(631,000)
Contracts receivable	(1,146,000)
Designated assets for return of capital	685,000
Accounts payable and accrued expenses	6,002,000	370,000
Deferred revenue	(13,711,000)	(16,582,000)
Other current liabilities	1,573,000	(396,000)
Right of use liability	(96,000)	(15,000)
Net cash used in continuing operations	(8,680,000)	(12,775,000)
Net cash used in discontinued operations		(5,895,000)
Net cash used in operating activities	(8,680,000)	(18,670,000)
Cash flows from investing activities:
Proceeds from sale of marketable securities	3,385,000	7,144,000
Proceeds from note receivable	900,000
Deferred payments to LD Micro		(3,004,000)
Proceeds from the sale of designated assets	506,000
Purchase of marketable securities		(429,000)
Acquisition of property and equipment	(108,000)	(97,000)
Acquisition of intangible assets	(388,000)	(541,000)
Other assets		(33,000)
Net cash from continuing operations	4,295,000	3,040,000
Net cash from discontinued operations		955,000
Net cash from investing activities	4,295,000	3,995,000
Cash flows from financing activities:
Preferred stock distributions	(365,000)
Proceeds from issuance of common stock		284,000
Payments of taxes related to settlement of restricted stock units	(101,000)
Proceeds from the exercise of warrants	32,000	15,953,000
Proceeds from factoring facilities	5,362,000
Repayments of factoring facilities	(6,184,000)
Repayments of OID convertible notes payable	(277,000)
Proceeds from senior secured revolving credit facility	4,686,000
Net cash from continuing operations	3,153,000	16,237,000
Net cash from discontinued operations		4,810,000
Net cash from financing activities	3,153,000	21,047,000
Net (decrease) increase in cash from continuing operations	(1,232,000)	6,502,000
Net decrease in cash from discontinued operations		(130,000)
Cash, beginning of period	1,348,000	451,000
Cash, end of period	116,000	6,823,000
Supplemental schedule of cash flow information
Cash paid for interest	77,000	14,000
Cash paid for taxes
Supplemental schedule of noncash investing and financing activities
Fair value of marketable securities received for revenue contracts, net	15,943,000	26,564,000
Convertible notes converted into shares		6,423,000
Designation of marketable securities for dividend distributions		6,387,000
Dividends on preferred stock		$ 6,387,000

ORGANIZATION AND LIQUIDITY

ORGANIZATION AND LIQUIDITY	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND LIQUIDITY	NOTE 1 – ORGANIZATION AND LIQUIDITY Organization SRAX, Inc. (“SRAX”, “we”, “us”, “our” or the “Company”) is a Delaware corporation formed on August 2, 2011. SRAX is headquartered in Westlake Village, California but operates as a distributed virtual Company. As of September 30, 2022, the unaudited Condensed Consolidated Financial Statements consist of SRAX and its wholly owned subsidiary LD Micro, Inc. (“LD Micro”). SRAX is a technology firm focused on enhancing communications between public companies and their shareholders and investors. The Company currently has one reportable and operating segment, which consists of one reporting unit consisting of two distinct business units: ● The unique SaaS platform, Sequire provides users many features which allow issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. ● Through LD Micro, the Company organizes and hosts investor conferences within the micro and small- cap markets, and plans to create several more niche events for the investor community. Each of SRAX’s business units deliver valuable insights that assist the Company’s clients with their investor relations and communications initiatives. On February 4, 2021, the Company acquired FPVD through a reverse acquisition involving BIG Token, Inc. On December 29, 2021, the Company deconsolidated the Company’s majority owned subsidiary BIG Token, Inc. (“BIGToken”) formerly known as Force Protection Video Equipment Corporation (or “FPVD”). See Note 3 –Discontinued Operations. On March 3, 2023, the Company divested the LD Micro subsidiary. Liquidity and Capital Resources The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. As of September 30, 2022, the Company had cash of $ 116,000 The unaudited Condensed Consolidated Financial Statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the unaudited Condensed Consolidated Financial Statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. In making this assessment, the Company performed a comprehensive analysis of current circumstances including: its financial position, cash flow and cash usage forecasts, and obligations and debts. Although management has a long history of successful capital raises, the analysis used to determine the Company’s ability as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next 12 months. The Company expects that its existing cash, accounts receivable and sale of marketable securities as of September 30, 2022, will not be sufficient to enable it to fund the anticipated level of operations through one year from the date these financial statements are issued. The Company projects the sale of its marketable security holding will represent a substantial portion of the cash required for operations for the foreseeable future. The Company’s sales of marketable securities are primarily through sale transactions that qualify for exemptions pursuant to Rule 144 of the Securities Act of 1933. The conditions required to be met to qualify for the exemptions under Rule 144 are often difficult to predict, making it difficult to predict the timing of the associated cash flows from the sales of these securities. The Company’s holdings of marketable securities are subject to risks and uncertainties such as fluctuations in pricing in the primary market, and legal restrictions that create uncertainty around realization and timing of cash flows. The Company anticipates raising additional capital through the private and public sales of its equity or debt securities and selling its marketable securities, or a combination thereof. Although management believes that such capital sources will be available, there can be no assurances that financing will be available when needed in order to allow the Company to continue its operations, or if available, on terms acceptable to it. If the Company does not raise sufficient capital in a timely manner, among other things, it may be forced to scale back its operations or cease operations altogether.

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying Condensed Consolidated Financial Statements and notes thereto are unaudited. The unaudited interim Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in the Company’s annual financial statements have been condensed or omitted. The December 31, 2021 Condensed Consolidated Balance Sheet was derived from financial statements but does not include all disclosures required by GAAP. These interim unaudited Condensed Consolidated Financial Statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim nine-month periods ended September 30, 2022 and 2021. The results for the nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or for any future period. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited Consolidated Financial Statements and the notes thereto for the year ended December 31, 2021, included in the Company’s annual report on Form 10-K filed with the SEC. Principles of Consolidation The unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. Reclassification Certain prior period amounts have been reclassified to conform to current period presentation. Use of Estimates The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with GAAP and require management of the Company to make estimates and assumptions in the preparation of these unaudited Condensed Consolidated Financial Statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions. The most significant areas that require management judgment and which are susceptible to possible change in the near term include, among other items, the Company’s revenue recognition, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisitions, goodwill, other intangible assets, and the valuation of redemption features and other assets and liabilities. Fair Value of Financial Instruments The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability. In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels: ● Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access; ● Level 2 - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and ● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the item being valued is classified based on the hierarchy category of the lowest significant level input to the fair value measurement. See Note 12 Fair Value of Financial Instruments. Cash The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash is recorded at cost, which approximates its fair value. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. The Company maintains its cash in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $ 250,000 0 1,098,000 Marketable Securities Marketable Securities consist of debt and equity securities. The Company accounts for marketable equity securities, including convertible preferred shares at fair value pursuant to ASC 321 Investments – Equity Securities, and marketable debt securities at fair value in accordance with ASC 320 – Investments Debt Securities. Marketable securities were approximately $ 21.1 15.6 Accounts Receivable Credit is extended to customers based on an evaluation of their financial condition and other factors, and the Company usually does not require collateral. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The allowance for doubtful accounts was approximately $ 69,000 130,000 Concentration of Credit and Significant Customer Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, accounts receivable and notes receivable. Cash is deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the FDIC insurance limits. The Company has not experienced any loss on these accounts. As of September 30, 2022, the Company did not have any customers with accounts receivable balances representing greater than 10% of the Company’s aggregate accounts receivable. As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately 11 For the nine months ended September 30, 2022 and 2021, the Company had no customers that account for a significant percentage of total revenues. Goodwill and Intangible assets Intangible assets consist of (i) goodwill, intellectual property, trademarks, trade names and non-compete agreements acquired in business combinations and capitalized software development costs. Other than goodwill and trademarks, intangible assets are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years. Impairment of Goodwill, Intangible Assets and Other Long-lived Assets Management evaluates the recoverability of the Company’s definitive lived intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Management evaluates the recoverability of the Company’s goodwill annually at December 31 or more often as events or circumstances indicate the fair value of a reporting unit is below its carrying value. The Company has determined that it operates as a single reporting unit for the purposes of conducting this goodwill impairment assessment. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. An impairment in the amount of $ 10,200,000 1,481,000 No Revenue Recognition The Company recognizes revenues upon the satisfaction of its performance obligation(s) (upon transfer of control of promised goods or services to its customers) in an amount that reflects the consideration to which it expects to be entitled to in exchange for those goods or services. The Company determines the amount of revenue to be recognized through the application of the five-step process as follows: 1) identification of contracts with customers; 2) identification of the distinct performance obligations in the contract; 3) determination of the transaction price of the contract; 4) allocation of transaction price among the performance obligations in the contract; and 5) recognition of revenue as performance obligations are satisfied. The Company has elected the following practical expedients allowed in accounting for its revenue recognition: ● not adjusting contract consideration for the effects of significant financing components if the period between transfer or service and customer payment is expected to be less than one year; ● not assessing performance obligations if they are immaterial in the context of the contract; ● excluding sales and similar taxes from the transaction price; and ● not disclosing the value of unsatisfied performance obligations for contracts with an original expected length of one year or less. The Company generates revenue primarily from its Sequire SaaS platform and its LD Micro subsidiary. Specifically, the Sequire SaaS platform related revenue consists of (i) licensing subscriptions to access the platform, (ii) managed services involving data and marketing initiatives and (iii) ancillary data supplementing the use of the platform. LD Micro revenues consist of attendee fees and event sponsorship fees related investor conferences organized and hosted by the Company. Sequire SaaS platform Sequire SaaS platform agreements are typically for a period of 12-months and provide for monthly or annual payments in advance. Prior to 2023 many of the Sequire SaaS platform agreements provide customers the ability to pay for the services with the issuance of the customers’ securities including common stock. The amount of consideration for these contracts is based on the estimated fair value of the underlying securities on the contract date. See “Fair Value of Financial Instruments” for details over the calculation of fair value. In 2023 the Company transitioned to accepting only cash as compensation for services. As we transition to accepting only cash as compensation for services there will be a significant decrease in Sequire revenue. When Sequire SaaS platform contracts contain multiple performance obligations, transaction consideration is allocated to each individual performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. The Company determines SSP based on the price at which the performance obligation would be sold separately. Subscription revenue is generally non-refundable regardless of the actual use and is recognized ratably over the non-cancellable contract term beginning on the commencement date of each contract, which is the date the Company’s service is first made available to customers. Managed Services and Ancillary Data revenue is typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. LD Micro - Conference Revenue LD Micro agreements cover a specific event and provide for payment in advance or at the time of the event. Conference revenue from attendee fees and sponsorship fees is recognized at the time of the event (i.e., at a point-in-time). Contracts Receivable Contracts receivable represents amounts for which non-cancellable revenue contracts with customers have been finalized but the payment in the form of securities issued by the customer have not been received by the Company. Deferred Revenue Deferred revenue resulting from amounts billed to, or cash received from, customers in advance of the Company satisfying its performance obligation and recognizing the applicable revenue. Preferred stock Preferred stock liability represents amounts payable to holders of the Preferred Stock Series A shares upon the eventual liquidation of assets designated for the sole purpose of paying dividends. Accordingly, the Company classified the Series A Preferred Shares as liability instruments because in-substance, they represent a right to the payment of dividends upon the liquidation of specified assets, are automatically returnable to the Company after the payments are made and feature no rights to further equity or residual interests in the Company. The Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Preferred Stock states dividend shall be paid conditioned upon, and subject to a determination by the Board that a distribution is not prohibited pursuant to applicable provisions of the DGCL or other applicable law. Costs to Obtain or Costs to Fulfill a Contract The Company has no costs that qualify as costs to obtain or costs to fulfill customer contracts. Net Loss Per Share Basic earnings per share is calculated by dividing net loss by the weighted-average number of shares outstanding during the period. Diluted loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding, after giving effect to all potentially dilutive common shares outstanding during the period. For periods with a net loss, basic and diluted earnings per share are the same, in that a potentially common stock equivalent would have the effect of being anti-dilutive in the computation of net loss per share. The number of potentially outstanding dilutive common shares excluded from the diluted net loss per calculation, as they were anti-dilutive were 911,868 11,867,520 Recent Accounting Pronouncements In June 2022, the FASB issued Accounting Standards Update (“ASU”) ASU 2022-03 (“ Fair Value Measurements Recent Accounting Pronouncements Not Yet Adopted In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, Debt-Debt with Conversion and Other Options In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) The Company’s management reviewed all recently issued ASU’s not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	NOTE 3 – DISCONTINUED OPERATIONS Background On February 4, 2021, the Company completed a share exchange agreement (“Exchange Agreement”) with FPVD. As part of the Exchange Agreement the Company transferred all of the BIGToken assets and 100 149,562,566,534 5,000,000 100 88.9 Deconsolidation On December 29, 2021, BIGToken (formerly FPVD) completed a merger transaction with BritePool, Inc. (“BritePool”) (the “Merger”) resulting in the Company’s ownership in BIGToken being reduced from 66% to approximately 4.99%. 183,445,351,631 149,562,566,534 242,078 22,162 13,692,304,136 4.99 Subsequent to the transaction, the Company now owns 220,000 13,692,304,136 loss of $ 10.7 SCHEDULE OF DECONSOLIDATION OF BUSINESS Consideration Amount Fair value of Series D Stock and Common Stock $ 31,000 Carrying amount of non-controlling interests of BIGToken 6,045,000 Previous equity adjustments of non-controlling interest (12,510,000 ) Total (6,434,000 ) Book basis of investment in BIGToken 4,250,000 Loss on disposal of subsidiary $ (10,684,000 ) The Company determined the Series D Stock would be classified as a Level 3 asset as there is no observable market for quoted market price for an identical asset. The Company engaged an independent third-party valuation expert to estimate the fair value of the Series D Stock. The financial results of BIGToken are presented as loss from discontinued operations, net of income taxes and net of income attributable to non-controlling interests on the Company’s unaudited Condensed Consolidated Statement of Operations for the three and nine months ended September 30, 2021. The historical Condensed Consolidated Statement of Cash Flows has also been revised to reflect the effect of the deconsolidation. The following table presents the financial results of BIGToken: SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS Three Months Ended Nine Months Ended Revenues $ 765,000 $ 2,469,000 Cost and expenses Cost of revenues 207,000 715,000 Employee related costs 988,000 2,649,000 Marketing and selling expenses 372,000 861,000 Platform costs 78,000 245,000 Depreciation and amortization 101,000 412,000 General and administrative expenses 1,078,000 3,483,000 Total cost and expenses 2,824,000 8,365,000 Loss from operations (2,059,000 ) (5,896,000 ) Other expense Deemed dividend on preferred stock - (5,859,000 ) Total other expense - (5,859,000 ) Loss from discontinued operations before income tax expense (2,059,000 ) (11,755,000 ) Income tax expense - - Loss from discontinued operations $ (2,059,000 ) $ (11,755,000 )

NOTES RECEIVABLE

NOTES RECEIVABLE	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
NOTES RECEIVABLE	NOTE 4 – NOTES RECEIVABLE In October 2020, the Company entered into unit redemption agreements with two counterparties providing for the counterparties to repurchase from the Company units of the counterparty’s securities owned by the Company. Pursuant to the redemption agreements, the counterparties repurchased the units for a combined repurchase price of $ 8 7 1 1 107,000 amortized over 3 years 900,000 0 935,000

MARKETABLE SECURITIES

MARKETABLE SECURITIES	9 Months Ended
	Sep. 30, 2022
Cash and Cash Equivalents [Abstract]
MARKETABLE SECURITIES	NOTE 5 – MARKETABLE SECURITIES The Company offers its customers the option to settle the contract price in the customer’s issued and publicly trading securities or securities convertible into publicly traded securities (e.g., convertible debt), which could be in the form of common stock, preferred stock or convertible debentures. The Company initially values the securities received at the fair market value on the date the contract is executed, which value is used for revenue recognition purposes. After receipt of the securities, the securities are accounted for as investments in debt and equity securities. The Company has concluded that all its debt securities should be classified as trading securities based on its intent to sell them in the near term. Debt securities classified as trading securities and the equity securities are measured at each reporting period at fair value with changes reported in earnings. Upon the sale of the securities, the Company recognizes the final realized gain or (loss) in the consolidated statement of operations as a component of net income (loss). As of September 30, 2022 marketable securities amounted to $ 21,121,000 2,918,000 18,203,000 The following tables summarize the changes in the Company’s marketable securities during the nine months ended September 30, 2022: SCHEDULE OF MARKETABLE SECURITIES Total Common Stock Convertible Debentures Preferred Stock Warrants Balance as of December 31, 2021 $ 15,617,000 $ 10,735,000 $ 4,187,000 $ 599,000 $ 96,000 Transfers - 356,000 (325,000 ) (31,000 ) - Additions 15,943,000 14,006,000 937,000 1,000,000 - Sales proceeds (3,385,000 ) (3,385,000 ) - - - Realized loss (6,521,000 ) (6,521,000 ) - - - Current period change in fair value (533,000 ) (3,462,000 ) 4,429,000 (1,467,000 ) (33,000 ) Balance as of September 30, 2022 $ 21,121,000 $ 11,729,000 $ 9,228,000 $ 101,000 $ 63,000 The Company’s sales of securities for the nine months ended September 30, 2022, was approximately $ 3.4 9.9 6.5 The equity securities may be accounted for and classified into two categories and accounted for as follows: ● Equity securities with a readily determinable fair value are reported at fair value, with unrealized gains and losses included in earnings. The fair value of equity investments with fair values is primarily obtained from third-party pricing services. ● Equity securities without a readily determinable fair value are reported at their cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer and their impact on fair value. For equity investments without readily determinable fair values, when an orderly transaction for the identical or similar investment of the same issuer is identified, the Company uses valuation techniques to evaluate the observed transaction(s) and adjust the fair value of the equity investment. Concentration Risk The Company’s holdings in marketable securities subject the Company to concentrations of market risks. As of September 30, 2022, the Company’s top marketable security position had a fair value of $ 2.3 11 8.7 41 13.0 61 Volatility The Company’s holdings in marketable securities are subject to a high level of volatility, and can experience drastic price changes. BIGtoken Investment On February 15, 2022, the Company entered into a simple agreement for future equity (the “SAFE”) with its former BIGToken subsidiary. Pursuant to the SAFE, the Company invested $ 1,000,000 0 Pursuant to the terms of the SAFE, at any time that BIGtoken sells its securities (a “Financing”) prior to the termination of the SAFE, the Company may, at its option, convert the SAFE into: (i) the number of shares of non-voting Series D Convertible Preferred Stock (“Series D Preferred Stock”) equal to such (a) SAFE Amount divided by (b) the lowest price per share of equity securities sold in any Financing (prior to the termination of the SAFE) multiplied by eighty percent (80%) (the “Conversion Price”) and (ii) such number of warrants to purchase Series D Preferred Stock (the “Warrants”) equal to the SAFE Amount divided by the Conversion Price. Upon issuance, the Warrants will (i) have a term of five (5) years, (ii) an exercise price equal to the Conversion Price, and (iii) contain price protection provisions for subsequent financings.

DESIGNATED ASSETS FOR RETURN OF

DESIGNATED ASSETS FOR RETURN OF CAPITAL	9 Months Ended
	Sep. 30, 2022
Designated Assets For Return Of Capital
DESIGNATED ASSETS FOR RETURN OF CAPITAL	NOTE 6 – DESIGNATED ASSETS FOR RETURN OF CAPITAL On August 17, 2021, the Company announced that it will be issuing a one-time dividend consisting of a share of Series A Preferred Stock to shareholders, debenture holders, and certain warrant holders (“Recipients”) of record on September 20, 2021. The Board of Directors designated certain of the Company’s marketable equity securities (“Designated Assets”) as of September 20, 2021 to be used when liquidated, as a return of capital to the Recipients. See Note 9 - Series A Preferred Stock for more details. The balance of designated assets consists of the following: SCHEDULE OF DESIGNATED ASSETS September 30, 2022 December 31, 2021 Cash $ - $ 686,000 Marketable equity securities 221,000 3,239,000 Total $ 221,000 $ 3,925,000 The marketable equity security activity in designated assets is as follows: SCHEDULE OF MARKETABLE EQUITY SECURITY ACTIVITY IN DESIGNATED ASSETS Total Balance as of December 31, 2021 $ 3,239,000 Sales proceeds (505,000 ) Realized loss (1,803,000 ) Current period change in fair value (710,000 ) Balance as of September 30, 2022 $ 221,000 The Company’s sale of marketable securities underlying designated assets for the nine months ended September 30, 2022, were approximately $ 0.5 2.3 1.8

SALES AND PURCHASE OF ACCOUNTS

SALES AND PURCHASE OF ACCOUNTS RECEIVABLE AND SHORT TERM FINANCINGS	9 Months Ended
	Sep. 30, 2022
Credit Loss [Abstract]
SALES AND PURCHASE OF ACCOUNTS RECEIVABLE AND SHORT TERM FINANCINGS	NOTE 7 – SALES AND PURCHASE OF ACCOUNTS RECEIVABLE AND SHORT TERM FINANCINGS Sales of Accounts Receivable In 2020, the Company entered into certain financing agreements providing for the sale, with full recourse, of certain of its accounts receivable. These transactions were accounted for as financing of accounts receivables and the related accounts receivable were not removed from the Company’s consolidated balance sheet at the time of the transaction; rather, a liability was recorded for the proceeds received. In 2020 subsequent to the transactions, the purchaser converted the payables into approximately $ 788,000 For the year ended December 31, 2021, the Company entered into agreements with a third-party lender whereby it sold the Company’s right to future subscription revenues of $ 625,000 576,000 4,170,000 3,044,000 In August 2022, proceeds from the Senior Secured Revolving Credit Facility were used to pay off the entire balance of outstanding borrowings. The amount of borrowings outstanding was approximately $ 0 633,000 CVR Agreement During the nine months ended September 30, 2022, the Company entered into an agreement with an institutional investor whereby in exchange for the payment of $ 405,000 the investor received (i) the right to receive the net proceeds upon the sale of certain marketable securities held by the Company with a guaranteed minimum return of 120% of such Purchase Price or $486,000 and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the sales of such securities. 613,000

OID CONVERTIBLE NOTE(S) PAYABLE

OID CONVERTIBLE NOTE(S) PAYABLE	9 Months Ended
	Sep. 30, 2022
Oid Convertible Notes Payable
OID CONVERTIBLE NOTE(S) PAYABLE	NOTE 8 – OID CONVERTIBLE NOTE(S) PAYABLE On June 30, 2020, the Company entered into a definitive securities purchase agreement (the “Securities Purchase Agreement or Transaction”) with certain accredited and institutional investors (the “Purchasers”) for the purchase and sale of an aggregate of: (i) $ 16,101,000 14,169,000 12 6,440,561 13,000,000 1,169,000 9,100,000 The Debentures pay interest in cash at the rate of 12.0 The Debentures had an original maturity date of December 31, 2021 but were extended three times and now mature on June 30, 2023 The Debentures are convertible at the option of the holder into shares of the Company’s common stock at an initial conversion price of $ 2.69 In the event a Purchaser converts a portion of its Debenture into shares of the Company’s Common Stock, such amount will be deducted from the next applicable Amortization Payment. In the event such conversion exceeds the next applicable Amortization Payment, such excess amount will be deducted, in reverse order, from future Amortization Payments. Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company. Subject to the Company’s compliance with certain conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that the Company (i) sells or reprices any securities (each, a “Redemption Financing”), or (ii) disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures. The Debentures also contain certain customary events of default provisions, including, but not limited to, payment default, breaches of covenants, the occurrence of an event of default under certain material contracts of the Company, failure to register the shares underlying the Debentures and Warrants, changes in control of the Company, delisting of its securities from its trading market, and the entering or filing of certain monetary judgments against the Company. Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the Purchaser’s election, immediately due and payable in cash. The Company is also prohibited from certain activities (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser), including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends. The Warrants are initially exercisable at $ 2.50 Pursuant to a registration rights agreement (“Registration Rights Agreement”), the Company has agreed to file a registration statement registering the resale of the shares of the common stock underlying the Debentures and the Warrants within forty-five days from the date of the Registration Rights Agreement. The Company also agrees to have the registration statement declared effective within 90 days from the date of the Registration Rights Agreement and keep the registration statement continuously effective until the earlier of (i) the date after which all of the securities to be registered thereunder have been sold, or (ii) the date on which all the securities to be registered thereunder may be sold without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 under the Securities Act. The Company is also obligated to pay the Investors, as partial liquidated damages, a fee of 2.0% of each Purchaser’s subscription amount per month in cash upon the occurrence of certain events, including the Company’s failure to file and/or have the registration statement declared effective within the time periods provided. As of June 30, 2022, the Company has continuously met its obligations under the Registration Rights Agreement. Bradley Woods & Co. Ltd. (“Placement Agent”) acted as the placement agent, in connection with the sale of the securities. Pursuant to an engagement agreement, the Company agreed to pay the Placement Agent a cash commission of $ 1,040,000 478,854 3.3625 8 360,000 The Company first allocated the cash proceeds to the loan and the equity classified warrants on a relative fair value basis, secondly, the proceeds were allocated to the beneficial conversion feature. The proceeds allocated to the warrants and the beneficial conversion feature resulted in a debt discount being amortized as additional interest expense using the effective interest method over the term. Extension of Outstanding Original Issue Discount Senior Secured Convertible Debentures On July 1, 2022, the holders (“Holders”) of $ 1,197,000 (i) extend the maturity date of the Debentures until June 30, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures. 1,197,000 Amendment of Convertible Debenture On September 13, 2023, the remaining Debenture, solely held by ATW Master Fund was temporarily amended for a period of up to fourteen months from the Effective date of September 11, 2023. The amendments include, but are not limited to, provisions related to the payment of amounts owing under the Credit Agreement from the proceeds of the sale of third-party securities held by the company. Per the agreement ATW shall receive one hundred percent of the proceeds from sales from third party securities owned by the Company until such time as outstanding amounts due under the respective agreements have been repaid. The Company shall maintain the rights to all proceeds from sales of the marketable securities once the amounts due to ATW have been satisfied. The Company also agreed to various covenants and conditions, including providing access to certain accounts and notifying ATW Opportunities and ATW Master Fund of material changes. The table below summarizes the Debenture related activity during the three and nine months ended September 30, 2022: SCHEDULE OF OID CONVERTIBLE DEBENTURES Principal Debt Discount Net Book Value Balance as of December 31, 2021 $ 1,267,000 $ (103,000 ) $ 1,164,000 Amortization - 17,000 17,000 Balance as of March 31, 2022 $ 1,267,000 $ (86,000 ) $ 1,181,000 Amortization - 16,000 16,000 Balance as of June 30, 2022 $ 1,267,000 $ (70,000 ) $ 1,197,000 Principal adjustments 74,000 - 74,000 Repayments (195,000 ) - (195,000 ) Amortization - 18,000 18,000 Balance as of September 30, 2022 $ 1,146,000 $ (52,000 ) $ 1,094,000

SENIOR SECURED REVOLVING CREDIT

SENIOR SECURED REVOLVING CREDIT FACILITY (REVOLVING NOTE)	9 Months Ended
	Sep. 30, 2022
Senior Secured Revolving Credit Facility
SENIOR SECURED REVOLVING CREDIT FACILITY (REVOLVING NOTE)	NOTE 9 – SENIOR SECURED REVOLVING CREDIT FACILITY (REVOLVING NOTE) Bridge Note On July 1, 2022, the Company issued an original issue discount bridge note in principal amount of $ 650,000 500,000 August 15, 2022 On August 8, 2022, as described below, the Bridge Note was exchanged for a revolving note in the Senior Secured Revolving Credit Facility. Senior Secured Revolving Credit Facility (Revolving Note) On August 8, 2022, the Company entered into a senior secured revolving credit facility agreement with ATW Opportunities fund to initially borrow up to $ 9,450,000 5.5 2,590,358 September 30, 2023 On closing, the lender advanced $ 5,580,000 4,930,000 650,000 3,870,000 The principal balance of each Revolving Note will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%, and 18% in the event of default. The Revolving Note have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents. Commencing on the first day of each month after the Effective Date, the outstanding balance of the Revolving Note will be paid as calculated based on a percentage of the Company’s collections from the sale of certain of its marketable securities. The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends, fundamental transactions and certain future sales of the Company’s Common Stock. As consideration for Lender entering into the Loan Documents, Lender will be entitled to receive, in addition to any payment made under the Credit Agreement, 10% of the net proceeds received by the Company from the sales of securities received during the term of the Revolving Note. For the Company to enter into the Credit Agreement, we were required to issue 33,000 Amendment of Senior Secured Revolving Credit Facility On September 13, 2023, the Revolving Note and Credit Agreement were temporarily amended for a period of up to fourteen months from the Effective date of September 11, 2023. The amendments include, but are not limited to, provisions related to the payment of amounts owing under the Credit Agreement from the proceeds of the sale of third-party securities held by the company. Per the agreement ATW shall receive one hundred percent of the proceeds from sales from third party securities owned by the Company until such time as outstanding amounts due under the respective agreements have been repaid. The Company shall maintain the rights to all proceeds from sales of the marketable securities once the amounts due to ATW have been satisfied. The Company also agreed to various covenants and conditions, including providing access to certain accounts and notifying ATW Opportunities and ATW Master Fund of material changes. The table below summarizes the senior secured revolving credit facility related activity during the three months ended September 30, 2022: SCHEDULE OF SENIOR SECURED REVOLVING CREDIT FACILITY RELATED ACTIVITY Principal Debt Discount Net Book Value Balance as of June 30, 2022 $ - $ - $ - Loan proceeds 6,128,000 - 6,128,000 Original issue discount - (750,000 ) (750,000 ) Repayments (4,000 ) - (4,000 ) Amortization - 104,000 104,000 Balance as of September 30, 2022 $ 6,124,000 $ (646,000 ) $ 5,478,000 Extension of Warrants As part of the transactions contemplated by the Revolving Note, the Company additionally agreed to extend the expiration dates of the following outstanding Common Stock purchase warrants held by the Lender or its affiliated entities until September 30, 2023: (a) a warrant to purchase 1,313,636 (b) a warrant to purchase 166,667 (c) a warrant to purchase 480,027 (d) a warrant to purchase 480,028

COMMON AND PREFERRED STOCK

COMMON AND PREFERRED STOCK	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
COMMON AND PREFERRED STOCK	NOTE 10 – COMMON AND PREFERRED STOCK Common Stock The Company’s certificate of incorporation provides for two classes of common stock: Class A common stock (authorized 250,000,000 0.001 9,000,000 0.001 In August 2021, the Board of Directors approved a share repurchase program pursuant to which the Company is authorized to repurchase up to $ 10,000,000 During the year ended December 31, 2021, the Company repurchased 155,000 793,000 No 9.2 During the year ended December 31, 2021, the Company sold 53,616 284,000 On January 2, 2022, Michael Malone, our former Chief Financial Officer exercised an option to purchase 100,000 57,016 16,732 26,252 During the month of January 2022, non-executive employees exercised a total of 227,667 161,938 65,729 During the month of July 2022, the Company issued 31,872 100,000 During the three months ended June 30, 2022, the Company issued 203,926 697,574 689,173 8,401 32,000 Preferred Stock The Company is authorized to issue 50,000,000 0.001 36,462,417 On September 20, 2021, the Company filed a certificate of designation (the “COD”) of preferences, rights, and limitations of Series A Non-Voting Preferred Stock (“Series A Preferred Stock”) with the Secretary of State of Delaware. Pursuant to the COD, the Company is authorized to issue up to 36,462,417 On September 27, 2021, the Company issued a one-time dividend of 36,462,417 As of the Record Date, the following holders of securities were entitled to receive the Dividend (collectively, the “Qualified Recipients): i. each outstanding share of Class A common stock (the “Common Stock”), of which 25,160,504 ii. each share of Common Stock underlying outstanding common stock purchase warrants containing a contractual right to receive the Dividend (“Warrants”) of which, 10,327,645 iii. each original issue discount senior convertible debenture (the “Debentures”) issued on June 30, 2021, containing a contractual right to receive the Dividend on an as converted to Common Stock basis, of which $ 2,486,275 974,268 The Company’s management has evaluated the Preferred Stock and determined that Preferred Stock is mandatorily redeemable upon the distribution of the net proceeds from the sale of the designated marketable securities. Accordingly, it is classified as a liability recorded at fair value, with changes in fair value being reflected in earnings. Preferred stock liability represents amounts payable to holders of the Preferred Stock Series A shares upon the eventual liquidation of assets designated for the sole purpose of paying dividends. Accordingly, the Company classified the Series A Preferred Shares as liability instruments because in-substance, they represent a right to the payment of dividends upon the liquidation of specified assets, are automatically returnable to the Company after the payments are made and feature no rights to further equity or residual interests in the Company. The Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Preferred Stock states dividend shall be paid conditioned upon, and subject to a determination by the Board that a distribution is not prohibited pursuant to applicable provisions of the DGCL or other applicable law.

EQUITY COMPENSATION PLANS AND W

EQUITY COMPENSATION PLANS AND WARRANTS	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
EQUITY COMPENSATION PLANS AND WARRANTS	NOTE 11 – EQUITY COMPENSATION PLANS AND WARRANTS Equity Compensation Plans As of September 30, 2022, the Company has approximately 228,000 For the nine months ended September 30, 2022, the Company issued the below shares and granted the following stock-based awards: On January 2, 2022, Michael Malone, our former Chief Financial Officer exercised an option to purchase 100,000 57,016 16,732 26,252 On January 3, 2022, we issued four (4) common stock purchase options to our non-employee directors, pursuant to our amended non-employee director compensation policy. Each option entitled the holder to purchase 29,533 4.35 128,500 1 7 100,000 During the month of January 2022, non-executive employees exercised a total of 227,667 161,938 65,729 On January 6, 2022, we issued non-executive employees, options to purchase 380,000 4.25 5 3 1,038,000 On January 6, 2022, we issued Christopher Miglino, our Chief Executive Officer, an option to purchase 120,000 4.25 7 3 356,000 On January 6, 2022, we issued an employee an option to purchase 100,000 4.25 7 3 296,000 On January 6, 2022, we issued Michael Malone, our former Chief Financial Officer, a conditional option to purchase 100,000 4.25 7 3 296,000 On January 6, 2022, we issued an employee an option to purchase an aggregate of 20,000 4.25 5 3 55,000 During the month of July 2022, the Company issued 31,872 100,000 The per-share fair value of each stock option with service conditions only granted in 2022 was determined on the grant date using the Black-Scholes option pricing model with the following assumptions: SCHEDULE OF FAIR VALUE STOCK OPTION ASSUMPTIONS Grant date 1/3/2022 1/6/2022 1/6/2022 Expected term (in years) 5.0 4.4 3.4 Risk-free interest rate 1.55 % 1.55 % 1.60 % Expected volatility 90.0 % 90.0 % 90.0 % Expected dividend yield - % - % - % The following table details provides a summary of the Company’s stock option activity for the nine months ended September 30, 2022: SCHEDULE OF STOCK OPTION ACTIVITY Option Shares Weighted Average Exercise Price Weighted Average Remaining Term (years) Aggregate Intrinsic Value Outstanding as of December 31, 2021 1,334,287 $ 3.02 2.4 $ - Granted 718,132 4.27 5.2 - Exercised (427,667 ) 3.21 - - Forfeited (110,000 ) 3.42 - - Outstanding as of September 30, 2022 1,514,752 $ 3.53 4.1 $ - Exercisable at September 30, 2022 756,486 $ 3.30 3.9 $ - During the three months ended September 30, 2022 the Company recorded stock based compensation in the amount of $ 281,000 908,000 1,139,000 (231,000) 1,139,000 1,139,000 During the three and nine months ended September 30, 2021, the Company recognized $ 253,000 757,000 The Company has included stock-based compensation expense in employee related costs on our unaudited Condensed Consolidated Statements of Operations. At September 30, 2022, there was $ 1,835,000 2.3 Warrants During the nine months ended September 30, 2022, the Company issued 203,926 697,574 689,173 8,401 32,000 76,190 5,177,327 Extension of Warrants As part of the transactions contemplated by the Revolving Note, the Company additionally agreed to extend the expiration dates of the following outstanding Common Stock purchase warrants held by the Lender or its affiliated entities until September 30, 2023: (a) a warrant to purchase 1,313,636 (b) a warrant to purchase 166,667 (c) a warrant to purchase 480,027 (d) a warrant to purchase 480,028 During the three months ended September 30, 2022, as a result of the extension of the warrant expiration dates, the Company recorded a warrant modification expense of $ 1,788,000 On February 21, 2021 the Company entered into an agreement with the certain Debenture holders to exercise 4,545,440 4,545,440 7.50 expiring on January 31, 2022 . The New Warrants expire on January 31, 2022. Each holder agreed to pay $ 0.125 11,022,000 11,363,000 568,000 909,000 7,737,000 96 11 5.83 In addition, during the nine months ended September 30, 2021, the Company: (i) received cash of approximately $ 4,774,000 349,197 1,710,078 In total the Company issued a total of 6,309,186 15,953,000 At September 30, 2022, the Company had the following outstanding and exercisable warrants: SUMMARY OF OUTSTANDING AND EXERCISABLE WARRANTS Warrant Shares Exercise Price Weighted Average 1,375,455 $ 2.50 1.0 1,160,056 3.00 1.0 478,854 3.36 0.1 1,047,778 4.00 0.0 17,749 4.50 1.9 77,800 5.00 1.5 4,157,692 $ 3.17 0.6

REVENUE

REVENUE	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
REVENUE	NOTE 12 – REVENUE The Company has two business units, one one one The following table summarizes revenue by revenue stream for the three and nine months ended September 30: SCHEDULE OF REVENUE BY REVENUE STREAM 2022 2021 2022 2021 Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Sequire platform revenue $ 5,306,000 $ 6,888,000 $ 19,225,000 $ 17,879,000 Conference revenue 3,000 - 1,305,000 390,000 Other revenue - - - 694,000 Total revenue $ 5,309,000 $ 6,888,000 $ 20,530,000 $ 18,963,000 The following table summarizes revenue recognized in exchange for customer securities and cash for the three and nine months ended September 30: SCHEDULE OF REVENUE RECOGNIZED IN EXCHANGE FOR CUSTOMER SECURITIES AND CASH 2022 2021 2022 2021 Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Customer securities $ 4,589,000 $ 6,409,000 $ 16,663,000 $ 15,035,000 Cash 720,000 479,000 3,867,000 3,928,000 Total revenue $ 5,309,000 $ 6,888,000 $ 20,530,000 $ 18,963,000 During 2023 the Company transitioned to accepting only cash as compensation for services. As we transition to accepting only cash as compensation for services there will be a significant decrease in Sequire revenue.

FAIR VALUE OF FINANCIAL INSTRUM

FAIR VALUE OF FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	NOTE 13 – FAIR VALUE OF FINANCIAL INSTRUMENTS The carrying amounts of certain financial instruments, including cash and accounts payable and accrued expenses, approximate their respective fair values due to the short-term nature of such instruments. The carrying amount of our debt and notes receivable approximate their fair value. Valuation of Marketable Securities An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. Warrants are initially valued at cost, if acquired for cash, or at intrinsic value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities are valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity. Investments in restricted securities of public companies cannot be offered for sale to the public until the Company complies with certain statutory requirements. Investments in restricted securities of public companies are generally categorized in Level 2 of the fair value hierarchy. However, investments in public companies may be categorized in Level 3 of the fair value hierarchy depending on the level of observable liquidity. Specifically, if the Company determines the market activity is not sufficient to conclude the market activity represents an Active Market. Assets and Liabilities Measured at Fair Value on a Recurring Basis The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The Company considers marketable securities without sufficient liquidity to sell within 6 months of the date of acquisition and securities that will not be eligible for resale in the public markets through Rule 144 for 1 year from the date acquisition to be valued with Level 2 inputs. The contracts receivables represent a forward contractual right to receive securities pursuant to a revenue contract. As of September 30, 2022 and December 31, 2021, the Company determined the value of the securities underlying the contract asset to have a fair value of $ 499,000 844,000 The Company had the following financial assets at September 30, 2022 and December 31, 2021: SCHEDULE OF ASSETS MEASURED AT FAIR VALUE Balance as of September 30, 2022 Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Marketable securities $ 21,121,000 $ 2,164,000 $ 9,483,000 $ 9,474,000 Designated assets marketable securities 221,000 105,000 116,000 - Contract assets 499,000 499,000 - - Total assets $ 21,841,000 $ 2,768,000 $ 9,599,000 $ 9,474,000 Liabilities: Series A Preferred Stock $ 1,045,000 $ - $ 1,045,000 $ - Total liabilities $ 1,045,000 $ - $ 1,045,000 $ - Balance as of December 31, 2021 Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Marketable securities $ 15,617,000 $ 6,134,000 $ 2,448,000 $ 7,035,000 Designated assets marketable securities 3,925,000 259,000 3,666,000 - Contract assets 844,000 - - 844,000 Total assets $ 20,386,000 $ 6,393,000 $ 6,114,000 $ 7,879,000 Liabilities: Series A Preferred Stock $ 3,925,000 $ - $ 3,925,000 $ - Total liabilities $ 3,925,000 $ - $ 3,925,000 $ - Changes in Level 3 assets measured at fair value The following table presents additional information about Level 3 assets measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of assets classified within the Level 3 category. As a result, the unrealized gains and losses for the assets and liabilities within the Level 3 category may include changes in fair value that were attributable to both observable and unobservable inputs. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Changes in Level 3 assets measured at fair value the nine months ended September 30, 2022, were as follows: SCHEDULE OF FAIR VALUE AT ASSETS Total Common Stock Convertible Debentures Preferred Stock Warrants Balance as of December 31, 2021 $ 7,035,000 $ 2,153,000 $ 4,187,000 $ 599,000 $ 96,000 Transfers (2,455,000 ) (2,099,000 ) (325,000 ) (31,000 ) - Additions 2,419,000 481,000 938,000 1,000,000 - Sales proceeds (156,000 ) (156,000 ) - - - Realized loss (60,000 ) (60,000 ) - - - Current period change in fair value 2,691,000 (238,000 ) 4,429,000 (1,467,000 ) (33,000 ) Balance as of September 30, 2022 $ 9,474,000 $ 81,000 $ 9,229,000 $ 101,000 $ 63,000 Valuation processes for Level 2 and 3 Fair Value Measurements Fair value measurement of certain of our marketable securities fall within Level 2 and 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs. The Company classifies certain assets as Level 3 assets if the estimated fair value was derived from level 3 inputs. The Company utilizes a put option pricing model to arrive at a discount for lack of marketability and liquidity associated with restrictions on sales into the public market. The Company generally classifies restricted securities in public companies as level 2, however in circumstances where the observed level of liquidity is low and the quoted market price is deemed unreliable they may be categorized in Level 3 of the fair value hierarchy. The Company considers marketable securities without sufficient liquidity to sell within 6 months of the date of acquisition and securities that will not be eligible for resale in the public markets through Rule 144 for 1 year from the date acquisition to be valued with Level 2 inputs. The fair value of the Company’s Series A Preferred Stock may change significantly, impacting the Company’s assumptions used to estimate its fair value. The valuation of the Series A Preferred Stock is primarily based on the valuation of its underlying marketable securities. The marketable securities that are underlying the Series A Preferred Stock are classified as Designated Assets on the Company’s balance sheet and include Level 1 and Level 2 marketable securities and cash. The following table lists the significant unobservable inputs used to value assets classified as Level 3 of September 30, 2022. The table is not intended to be all-inclusive, but instead identifies the significant unobservable inputs relevant to the determination of fair values. The other Level 3 assets have been valued using unadjusted third-party transactions and, unadjusted historical third-party information, or the unadjusted net asset values of the securities’ issuer. No unobservable inputs internally developed by the Company have been applied to these assets, and therefore are omitted from the following table. SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS Assets Valuation Technique Unobservable inputs Range Common stocks Put option pricing model Discount for lack of marketability 0 32.3 % Convertible preferred stock Put option pricing model Discount for lack of marketability 0 54 % Convertible debt Discounted cash flow Maturity 0 28 Risk adjusted discount factor 17.3 % Option pricing model Volatility 64 224 % Risk-free interest rate 2.27 2.96 % Dividend yield 0 % Time to Maturity 0 28 Sensitivity of Level 3 measurements to changes in significant unobservable inputs The process of estimating the fair value of securities without active markets involves significant estimates and judgement on behalf of management. These estimated fair values may not be realized in a current sale or immediate settlement of the asset or liability. Additionally, there are inherent uncertainties in any fair value measurement techniques, and changes in the underlying assumptions used could significantly affect the fair value measurement amounts. Changes in each of these significant unobservable valuation inputs will impact the fair value measurement of the financial instrument generally as follows: ● An increase or decrease in the volatility of the common stock that underlies our holdings in convertible debt would result in a directionally similar change in the estimated fair value. ● An increase or decrease in the risk-free interest rate or risk adjusted discount factor would result in an inverse change in the estimated fair value of our convertible debt. ● An increase in the dividend yield would increase the estimated value of the convertible debt. ● A change in the maturity may result in either an increase or decrease in estimated fair value of the convertible debt. ● An increase or decrease in the discount for lack of marketability of our common stock holdings and the common stock that underlies our preferred stock would generally result in an inverse change in the estimated fair value. Instruments for which unobservable inputs are significant to their fair value measurement (i.e., Level 3) include securities in which we deem their market to be inactive or unreliable. The Company reviews and updates the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next that are related to the observable inputs to a fair value measurement may result in a reclassification from one hierarchy level to another.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 14 – RELATED PARTY TRANSACTIONS The Company has entered into an agreement providing access to a suite at the Sofi Stadium in Los Angeles from an entity wholly owned by Christopher Miglino, our CEO. The agreement entitles the Company to game tickets, optional tickets for other stadium events, and suite and conference room access during business days. In May of 2022, the Company renewed the agreement for four (4) additional National Football League seasons for an average rate per year of approximately $ 497,000

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 15 – SUBSEQUENT EVENTS DNA Asset Acquisition Asset Purchase Agreement On February 3, 2023 (the “Closing Date”), the Company entered into and consummated the transactions contemplated by the Asset Purchase Agreement (the “APA”) and the related Bill of Sale and Assignment and Assumption Agreement (the “Assignment Agreement,” and together with the Assignment Agreement, the “Transaction Documents”) with DNA Holdings, LLC, a limited liability company formed under the laws of the Commonwealth of Puerto Rico (the “Seller”), pursuant to which, subject to the terms and conditions of the APA, the Seller sold certain assets from its advisory company that is engaged in the business of, among other things, advising entrepreneurs in connection with capital structuring, marketing, developing decentralized ecosystems and providing introductions to strategic investors (the “Business”). Specifically, pursuant to the Transaction Documents, the Company acquired certain assets of the Business (the “Purchased Assets”), including $ 1,000,000 Pursuant to the terms of the APA, at the closing of the Acquisition (the “Closing”), in exchange for the Purchased Assets, the Company issued and delivered to Seller (i) 1,313,127 shares of the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”), and (ii) 63,743 shares of the Company’s newly designated class of Series B Non-Voting Convertible Preferred Stock (the “Series B Preferred Stock”) convertible, subject to the receipt of Stockholder Approval (as defined below), into an aggregate of 3,059,664 shares of Common Stock (collectively, the “Upfront Shares”). In addition to the Upfront Shares, the Company delivered into escrow 54,908 shares of Series B Preferred Stock convertible, subject to receipt of Stockholder Approval and the Deferred Payment (as defined below), into 2,635,591 shares of Common Stock (the “Escrow Shares,” together with the Upfront Shares, the “Acquisition Shares”). In accordance with applicable Nasdaq listing rules, the Company plans to obtain stockholder approval to issue the shares of Common Stock underlying the Series B Preferred Stock so that it may issue shares of Common Stock to the Seller in excess of 1,313,127 shares of Common Stock, the amount of shares equal to 4.99% of the issued and outstanding Common Stock on the Closing Date (“Stockholder Approval”). Within thirty (30) days, but not earlier than fifteen (15) business days after Stockholder Approval is obtained, the Seller will prepare and deliver to the Company a written determination, in the Seller’s sole and absolute discretion, of an amount equal to or less than $2,000,000 to be paid to the Company, if any (such amount to be paid to the Company, the “Deferred Payment” and such amount that will not be paid to the Company, the “Uncollected Deferred Payment”). Within five (5) business days of the delivery of such written determination, subject and upon receipt of the Deferred Payment, the Company and the Seller will instruct the Escrow Agent to release to the Company such number of Escrow Shares based upon the shares of Common Stock underlying the Series B Preferred Stock multiplied by the quotient of (i) the outstanding Uncollected Deferred Payment divided by (ii) $2,000,000. The balance of the Escrow Shares will then be released to the Seller (the “Post-Closing Adjustment”). In the event Stockholder Approval is not received on or prior to the eighteen (18) month anniversary of the Closing, the Deferred Payment will lapse and the Escrow Shares will all be released to the Company Amendment and Waiver Agreements On February 3, 2023, the Company entered into an amendment and waiver agreement (the “Amendment and Waiver Agreement”) with the ATW Fund I, L.P., ATW Master Fund II, L.P. and ATW Opportunities Master Fund II, LP (each, a “Holder” and, collectively, the “Holders”), pursuant to which the parties agreed to amend or modify certain outstanding agreements to permit the consummation of the Acquisition and avoid any potential noncompliance or events of default relating to such prior agreements. The exercise and conversion prices in these agreements were amended to $ 1.00 1,363,636 166,667 530,027 530,028 Sale of LD Micro, Inc. On March 3, 2023, the Company entered into and consummated the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”) with Freedom Holding Corp., a Nevada corporation (the “Parent”), Freedom U.S. Markets, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Parent (the “Buyer”), LDM Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Buyer (“Merger Sub”), LD Micro, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“LD Micro”), to sell LD Micro. Specifically, pursuant to the terms of the Merger Agreement, at the closing of the transactions contemplated by the Merger Agreement (the “Closing”), LD Micro merged with and into Merger Sub (the “Merger”), with Merger Sub surviving the Merger (the “Surviving Corporation”), in a transaction intended to qualify for tax-free treatment under Section 368(a) of the Internal Revenue Code of 1986, as amended. At the Closing, as consideration for the sale of LD Micro by means of the Merger, the Buyer paid the Company $ 8,300,000 4,000,000 59,763 0.001 4,300,000 LD Micro’s President, Christopher Lahiji, is a member of the Company’s board of directors (the “Board”). The Merger was approved on March 2, 2023, by the Board. In such case, it was considered that Mr. Lahiji is an interested director of the Company with respect to the Merger. In such case, it also was determined, among other things, that, notwithstanding that Mr. Lahiji is an interested director of the Company, the Merger Consideration received for the sale of LD Micro, by means of the Merger, constitute fair and adequate consideration. Further, in connection with the Merger, the Company also entered into a sponsorship agreement with the Surviving Corporation (the “Sponsorship Agreement”), whereby the Surviving Corporation agreed to designate the Company as an exclusive sponsor of certain flagship events that will be organized by the Surviving Corporation after the consummation of the Merger for a period of four (4) years and to provide certain benefits to the Company which include (i) exclusive virtual and live streaming partner for the events; (ii) exclusive partner to provide video recording interviews; and (iii) certain exclusivity to be the only sponsor providing SAAS platform services and digital marketing and services at the events. Creation of Advisory Board and Stock Compensation On July 17, 2023 the Company’s Board of Directors authorized the creation of an Advisory Board (“Advisory Board”) to provide strategic guidance and expertise to the Company in the financial technology sector. The establishment of the Advisory Board is aimed at enhancing the Company’s growth strategies and leveraging the insights and experience of industry leaders. As part of the establishment of the Advisory Board, the Company has granted a total of 500,000 Amendment of Senior Secured Revolving Credit Facility and Senior Secured Convertible Debenture The Company previously entered into a Senior Secured Revolving Credit Facility Agreement with ATW Opportunities fund, dated as of August 8, 2022, pursuant to which the Company issued a revolving note to ATW Opportunities (the “Revolving Note”). Additionally, the Company issued a Senior Secured Convertible Debenture to ATW Master Fund on June 30, 2020 (the “Debenture”). On September 13, 2023, the Revolving Note, Debenture, and Credit Agreement were temporarily amended for a period of up to fourteen months from the Effective date of September 11, 2023. The amendments include, but are not limited to, provisions related to the payment of amounts owing under the Credit Agreement from the proceeds of the sale of third-party securities held by the company. Per the agreement ATW shall receive one hundred percent of the proceeds from sales from third party securities owned by the Company until such time as outstanding amounts due under the respective agreements have been repaid. The Company shall maintain the rights to all proceeds from sales of the marketable securities once the amounts due to ATW have been satisfied. The Company also agreed to various covenants and conditions, including providing access to certain accounts and notifying ATW Opportunities and ATW Master Fund of material changes.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Condensed Consolidated Financial Statements and notes thereto are unaudited. The unaudited interim Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in the Company’s annual financial statements have been condensed or omitted. The December 31, 2021 Condensed Consolidated Balance Sheet was derived from financial statements but does not include all disclosures required by GAAP. These interim unaudited Condensed Consolidated Financial Statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim nine-month periods ended September 30, 2022 and 2021. The results for the nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or for any future period. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited Consolidated Financial Statements and the notes thereto for the year ended December 31, 2021, included in the Company’s annual report on Form 10-K filed with the SEC.
Principles of Consolidation	Principles of Consolidation The unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.
Reclassification	Reclassification Certain prior period amounts have been reclassified to conform to current period presentation.
Use of Estimates	Use of Estimates The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with GAAP and require management of the Company to make estimates and assumptions in the preparation of these unaudited Condensed Consolidated Financial Statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions. The most significant areas that require management judgment and which are susceptible to possible change in the near term include, among other items, the Company’s revenue recognition, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisitions, goodwill, other intangible assets, and the valuation of redemption features and other assets and liabilities.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability. In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels: ● Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access; ● Level 2 - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and ● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the item being valued is classified based on the hierarchy category of the lowest significant level input to the fair value measurement. See Note 12 Fair Value of Financial Instruments.
Cash	Cash The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash is recorded at cost, which approximates its fair value. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. The Company maintains its cash in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $ 250,000 0 1,098,000
Marketable Securities	Marketable Securities Marketable Securities consist of debt and equity securities. The Company accounts for marketable equity securities, including convertible preferred shares at fair value pursuant to ASC 321 Investments – Equity Securities, and marketable debt securities at fair value in accordance with ASC 320 – Investments Debt Securities. Marketable securities were approximately $ 21.1 15.6
Accounts Receivable	Accounts Receivable Credit is extended to customers based on an evaluation of their financial condition and other factors, and the Company usually does not require collateral. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The allowance for doubtful accounts was approximately $ 69,000 130,000
Concentration of Credit and Significant Customer Risk	Concentration of Credit and Significant Customer Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, accounts receivable and notes receivable. Cash is deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the FDIC insurance limits. The Company has not experienced any loss on these accounts. As of September 30, 2022, the Company did not have any customers with accounts receivable balances representing greater than 10% of the Company’s aggregate accounts receivable. As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately 11 For the nine months ended September 30, 2022 and 2021, the Company had no customers that account for a significant percentage of total revenues.
Goodwill and Intangible assets	Goodwill and Intangible assets Intangible assets consist of (i) goodwill, intellectual property, trademarks, trade names and non-compete agreements acquired in business combinations and capitalized software development costs. Other than goodwill and trademarks, intangible assets are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years.
Impairment of Goodwill, Intangible Assets and Other Long-lived Assets	Impairment of Goodwill, Intangible Assets and Other Long-lived Assets Management evaluates the recoverability of the Company’s definitive lived intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Management evaluates the recoverability of the Company’s goodwill annually at December 31 or more often as events or circumstances indicate the fair value of a reporting unit is below its carrying value. The Company has determined that it operates as a single reporting unit for the purposes of conducting this goodwill impairment assessment. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. An impairment in the amount of $ 10,200,000 1,481,000 No
Revenue Recognition	Revenue Recognition The Company recognizes revenues upon the satisfaction of its performance obligation(s) (upon transfer of control of promised goods or services to its customers) in an amount that reflects the consideration to which it expects to be entitled to in exchange for those goods or services. The Company determines the amount of revenue to be recognized through the application of the five-step process as follows: 1) identification of contracts with customers; 2) identification of the distinct performance obligations in the contract; 3) determination of the transaction price of the contract; 4) allocation of transaction price among the performance obligations in the contract; and 5) recognition of revenue as performance obligations are satisfied. The Company has elected the following practical expedients allowed in accounting for its revenue recognition: ● not adjusting contract consideration for the effects of significant financing components if the period between transfer or service and customer payment is expected to be less than one year; ● not assessing performance obligations if they are immaterial in the context of the contract; ● excluding sales and similar taxes from the transaction price; and ● not disclosing the value of unsatisfied performance obligations for contracts with an original expected length of one year or less. The Company generates revenue primarily from its Sequire SaaS platform and its LD Micro subsidiary. Specifically, the Sequire SaaS platform related revenue consists of (i) licensing subscriptions to access the platform, (ii) managed services involving data and marketing initiatives and (iii) ancillary data supplementing the use of the platform. LD Micro revenues consist of attendee fees and event sponsorship fees related investor conferences organized and hosted by the Company. Sequire SaaS platform Sequire SaaS platform agreements are typically for a period of 12-months and provide for monthly or annual payments in advance. Prior to 2023 many of the Sequire SaaS platform agreements provide customers the ability to pay for the services with the issuance of the customers’ securities including common stock. The amount of consideration for these contracts is based on the estimated fair value of the underlying securities on the contract date. See “Fair Value of Financial Instruments” for details over the calculation of fair value. In 2023 the Company transitioned to accepting only cash as compensation for services. As we transition to accepting only cash as compensation for services there will be a significant decrease in Sequire revenue. When Sequire SaaS platform contracts contain multiple performance obligations, transaction consideration is allocated to each individual performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. The Company determines SSP based on the price at which the performance obligation would be sold separately. Subscription revenue is generally non-refundable regardless of the actual use and is recognized ratably over the non-cancellable contract term beginning on the commencement date of each contract, which is the date the Company’s service is first made available to customers. Managed Services and Ancillary Data revenue is typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. LD Micro - Conference Revenue LD Micro agreements cover a specific event and provide for payment in advance or at the time of the event. Conference revenue from attendee fees and sponsorship fees is recognized at the time of the event (i.e., at a point-in-time). Contracts Receivable Contracts receivable represents amounts for which non-cancellable revenue contracts with customers have been finalized but the payment in the form of securities issued by the customer have not been received by the Company. Deferred Revenue Deferred revenue resulting from amounts billed to, or cash received from, customers in advance of the Company satisfying its performance obligation and recognizing the applicable revenue. Preferred stock Preferred stock liability represents amounts payable to holders of the Preferred Stock Series A shares upon the eventual liquidation of assets designated for the sole purpose of paying dividends. Accordingly, the Company classified the Series A Preferred Shares as liability instruments because in-substance, they represent a right to the payment of dividends upon the liquidation of specified assets, are automatically returnable to the Company after the payments are made and feature no rights to further equity or residual interests in the Company. The Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Preferred Stock states dividend shall be paid conditioned upon, and subject to a determination by the Board that a distribution is not prohibited pursuant to applicable provisions of the DGCL or other applicable law. Costs to Obtain or Costs to Fulfill a Contract The Company has no costs that qualify as costs to obtain or costs to fulfill customer contracts.
Net Loss Per Share	Net Loss Per Share Basic earnings per share is calculated by dividing net loss by the weighted-average number of shares outstanding during the period. Diluted loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding, after giving effect to all potentially dilutive common shares outstanding during the period. For periods with a net loss, basic and diluted earnings per share are the same, in that a potentially common stock equivalent would have the effect of being anti-dilutive in the computation of net loss per share. The number of potentially outstanding dilutive common shares excluded from the diluted net loss per calculation, as they were anti-dilutive were 911,868 11,867,520
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2022, the FASB issued Accounting Standards Update (“ASU”) ASU 2022-03 (“ Fair Value Measurements Recent Accounting Pronouncements Not Yet Adopted In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, Debt-Debt with Conversion and Other Options In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) The Company’s management reviewed all recently issued ASU’s not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Sep. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
SCHEDULE OF DECONSOLIDATION OF BUSINESS	SCHEDULE OF DECONSOLIDATION OF BUSINESS Consideration Amount Fair value of Series D Stock and Common Stock $ 31,000 Carrying amount of non-controlling interests of BIGToken 6,045,000 Previous equity adjustments of non-controlling interest (12,510,000 ) Total (6,434,000 ) Book basis of investment in BIGToken 4,250,000 Loss on disposal of subsidiary $ (10,684,000 )
SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS	SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS Three Months Ended Nine Months Ended Revenues $ 765,000 $ 2,469,000 Cost and expenses Cost of revenues 207,000 715,000 Employee related costs 988,000 2,649,000 Marketing and selling expenses 372,000 861,000 Platform costs 78,000 245,000 Depreciation and amortization 101,000 412,000 General and administrative expenses 1,078,000 3,483,000 Total cost and expenses 2,824,000 8,365,000 Loss from operations (2,059,000 ) (5,896,000 ) Other expense Deemed dividend on preferred stock - (5,859,000 ) Total other expense - (5,859,000 ) Loss from discontinued operations before income tax expense (2,059,000 ) (11,755,000 ) Income tax expense - - Loss from discontinued operations $ (2,059,000 ) $ (11,755,000 )

MARKETABLE SECURITIES (Tables)

MARKETABLE SECURITIES (Tables)	9 Months Ended
	Sep. 30, 2022
Cash and Cash Equivalents [Abstract]
SCHEDULE OF MARKETABLE SECURITIES	SCHEDULE OF MARKETABLE SECURITIES Total Common Stock Convertible Debentures Preferred Stock Warrants Balance as of December 31, 2021 $ 15,617,000 $ 10,735,000 $ 4,187,000 $ 599,000 $ 96,000 Transfers - 356,000 (325,000 ) (31,000 ) - Additions 15,943,000 14,006,000 937,000 1,000,000 - Sales proceeds (3,385,000 ) (3,385,000 ) - - - Realized loss (6,521,000 ) (6,521,000 ) - - - Current period change in fair value (533,000 ) (3,462,000 ) 4,429,000 (1,467,000 ) (33,000 ) Balance as of September 30, 2022 $ 21,121,000 $ 11,729,000 $ 9,228,000 $ 101,000 $ 63,000

DESIGNATED ASSETS FOR RETURN _2

DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables)	9 Months Ended
	Sep. 30, 2022
Designated Assets For Return Of Capital
SCHEDULE OF DESIGNATED ASSETS	The balance of designated assets consists of the following: SCHEDULE OF DESIGNATED ASSETS September 30, 2022 December 31, 2021 Cash $ - $ 686,000 Marketable equity securities 221,000 3,239,000 Total $ 221,000 $ 3,925,000
SCHEDULE OF MARKETABLE EQUITY SECURITY ACTIVITY IN DESIGNATED ASSETS	The marketable equity security activity in designated assets is as follows: SCHEDULE OF MARKETABLE EQUITY SECURITY ACTIVITY IN DESIGNATED ASSETS Total Balance as of December 31, 2021 $ 3,239,000 Sales proceeds (505,000 ) Realized loss (1,803,000 ) Current period change in fair value (710,000 ) Balance as of September 30, 2022 $ 221,000

OID CONVERTIBLE NOTE(S) PAYAB_2

OID CONVERTIBLE NOTE(S) PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2022
Oid Convertible Notes Payable
SCHEDULE OF OID CONVERTIBLE DEBENTURES	The table below summarizes the Debenture related activity during the three and nine months ended September 30, 2022: SCHEDULE OF OID CONVERTIBLE DEBENTURES Principal Debt Discount Net Book Value Balance as of December 31, 2021 $ 1,267,000 $ (103,000 ) $ 1,164,000 Amortization - 17,000 17,000 Balance as of March 31, 2022 $ 1,267,000 $ (86,000 ) $ 1,181,000 Amortization - 16,000 16,000 Balance as of June 30, 2022 $ 1,267,000 $ (70,000 ) $ 1,197,000 Principal adjustments 74,000 - 74,000 Repayments (195,000 ) - (195,000 ) Amortization - 18,000 18,000 Balance as of September 30, 2022 $ 1,146,000 $ (52,000 ) $ 1,094,000

SENIOR SECURED REVOLVING CRED_2

SENIOR SECURED REVOLVING CREDIT FACILITY (REVOLVING NOTE) (Tables)	9 Months Ended
	Sep. 30, 2022
Senior Secured Revolving Credit Facility
SCHEDULE OF SENIOR SECURED REVOLVING CREDIT FACILITY RELATED ACTIVITY	The table below summarizes the senior secured revolving credit facility related activity during the three months ended September 30, 2022: SCHEDULE OF SENIOR SECURED REVOLVING CREDIT FACILITY RELATED ACTIVITY Principal Debt Discount Net Book Value Balance as of June 30, 2022 $ - $ - $ - Loan proceeds 6,128,000 - 6,128,000 Original issue discount - (750,000 ) (750,000 ) Repayments (4,000 ) - (4,000 ) Amortization - 104,000 104,000 Balance as of September 30, 2022 $ 6,124,000 $ (646,000 ) $ 5,478,000

EQUITY COMPENSATION PLANS AND_2

EQUITY COMPENSATION PLANS AND WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
SCHEDULE OF STOCK OPTION ACTIVITY	The per-share fair value of each stock option with service conditions only granted in 2022 was determined on the grant date using the Black-Scholes option pricing model with the following assumptions: SCHEDULE OF FAIR VALUE STOCK OPTION ASSUMPTIONS Grant date 1/3/2022 1/6/2022 1/6/2022 Expected term (in years) 5.0 4.4 3.4 Risk-free interest rate 1.55 % 1.55 % 1.60 % Expected volatility 90.0 % 90.0 % 90.0 % Expected dividend yield - % - % - % The following table details provides a summary of the Company’s stock option activity for the nine months ended September 30, 2022: SCHEDULE OF STOCK OPTION ACTIVITY Option Shares Weighted Average Exercise Price Weighted Average Remaining Term (years) Aggregate Intrinsic Value Outstanding as of December 31, 2021 1,334,287 $ 3.02 2.4 $ - Granted 718,132 4.27 5.2 - Exercised (427,667 ) 3.21 - - Forfeited (110,000 ) 3.42 - - Outstanding as of September 30, 2022 1,514,752 $ 3.53 4.1 $ - Exercisable at September 30, 2022 756,486 $ 3.30 3.9 $ -
SCHEDULE OF STOCK OPTION ACTIVITY	The following table details provides a summary of the Company’s stock option activity for the nine months ended September 30, 2022: SCHEDULE OF STOCK OPTION ACTIVITY Option Shares Weighted Average Exercise Price Weighted Average Remaining Term (years) Aggregate Intrinsic Value Outstanding as of December 31, 2021 1,334,287 $ 3.02 2.4 $ - Granted 718,132 4.27 5.2 - Exercised (427,667 ) 3.21 - - Forfeited (110,000 ) 3.42 - - Outstanding as of September 30, 2022 1,514,752 $ 3.53 4.1 $ - Exercisable at September 30, 2022 756,486 $ 3.30 3.9 $ -
SUMMARY OF OUTSTANDING AND EXERCISABLE WARRANTS	At September 30, 2022, the Company had the following outstanding and exercisable warrants: SUMMARY OF OUTSTANDING AND EXERCISABLE WARRANTS Warrant Shares Exercise Price Weighted Average 1,375,455 $ 2.50 1.0 1,160,056 3.00 1.0 478,854 3.36 0.1 1,047,778 4.00 0.0 17,749 4.50 1.9 77,800 5.00 1.5 4,157,692 $ 3.17 0.6

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
SCHEDULE OF REVENUE BY REVENUE STREAM	The following table summarizes revenue by revenue stream for the three and nine months ended September 30: SCHEDULE OF REVENUE BY REVENUE STREAM 2022 2021 2022 2021 Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Sequire platform revenue $ 5,306,000 $ 6,888,000 $ 19,225,000 $ 17,879,000 Conference revenue 3,000 - 1,305,000 390,000 Other revenue - - - 694,000 Total revenue $ 5,309,000 $ 6,888,000 $ 20,530,000 $ 18,963,000
SCHEDULE OF REVENUE RECOGNIZED IN EXCHANGE FOR CUSTOMER SECURITIES AND CASH	The following table summarizes revenue recognized in exchange for customer securities and cash for the three and nine months ended September 30: SCHEDULE OF REVENUE RECOGNIZED IN EXCHANGE FOR CUSTOMER SECURITIES AND CASH 2022 2021 2022 2021 Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Customer securities $ 4,589,000 $ 6,409,000 $ 16,663,000 $ 15,035,000 Cash 720,000 479,000 3,867,000 3,928,000 Total revenue $ 5,309,000 $ 6,888,000 $ 20,530,000 $ 18,963,000

FAIR VALUE OF FINANCIAL INSTR_2

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
SCHEDULE OF ASSETS MEASURED AT FAIR VALUE	SCHEDULE OF ASSETS MEASURED AT FAIR VALUE Balance as of September 30, 2022 Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Marketable securities $ 21,121,000 $ 2,164,000 $ 9,483,000 $ 9,474,000 Designated assets marketable securities 221,000 105,000 116,000 - Contract assets 499,000 499,000 - - Total assets $ 21,841,000 $ 2,768,000 $ 9,599,000 $ 9,474,000 Liabilities: Series A Preferred Stock $ 1,045,000 $ - $ 1,045,000 $ - Total liabilities $ 1,045,000 $ - $ 1,045,000 $ - Balance as of December 31, 2021 Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Marketable securities $ 15,617,000 $ 6,134,000 $ 2,448,000 $ 7,035,000 Designated assets marketable securities 3,925,000 259,000 3,666,000 - Contract assets 844,000 - - 844,000 Total assets $ 20,386,000 $ 6,393,000 $ 6,114,000 $ 7,879,000 Liabilities: Series A Preferred Stock $ 3,925,000 $ - $ 3,925,000 $ - Total liabilities $ 3,925,000 $ - $ 3,925,000 $ -
SCHEDULE OF FAIR VALUE AT ASSETS	SCHEDULE OF FAIR VALUE AT ASSETS Total Common Stock Convertible Debentures Preferred Stock Warrants Balance as of December 31, 2021 $ 7,035,000 $ 2,153,000 $ 4,187,000 $ 599,000 $ 96,000 Transfers (2,455,000 ) (2,099,000 ) (325,000 ) (31,000 ) - Additions 2,419,000 481,000 938,000 1,000,000 - Sales proceeds (156,000 ) (156,000 ) - - - Realized loss (60,000 ) (60,000 ) - - - Current period change in fair value 2,691,000 (238,000 ) 4,429,000 (1,467,000 ) (33,000 ) Balance as of September 30, 2022 $ 9,474,000 $ 81,000 $ 9,229,000 $ 101,000 $ 63,000
SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS	SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS Assets Valuation Technique Unobservable inputs Range Common stocks Put option pricing model Discount for lack of marketability 0 32.3 % Convertible preferred stock Put option pricing model Discount for lack of marketability 0 54 % Convertible debt Discounted cash flow Maturity 0 28 Risk adjusted discount factor 17.3 % Option pricing model Volatility 64 224 % Risk-free interest rate 2.27 2.96 % Dividend yield 0 % Time to Maturity 0 28

ORGANIZATION AND LIQUIDITY (Det

ORGANIZATION AND LIQUIDITY (Details Narrative) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 116,000	$ 1,348,000

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Product Information [Line Items]
FDIC amount	$ 250,000		$ 250,000
Excess of federal insurance limit	0		0		$ 1,098,000
Marketable securities	21,121,000		21,121,000		15,617,000
Allowance for doubtful accounts	69,000		69,000		$ 130,000
Impairment of goodwill			10,200,000
Impairment of intangibles			$ 1,481,000
Potentially Diluted Basic in Future [Member]
Product Information [Line Items]
Anti diluted net income securities	911,868	11,867,520	911,868	11,867,520
Customer Concentration Risk [Member] | Accounts Receivable [Member] | One Customer [Member]
Product Information [Line Items]
Concentration risk percentage					11%

SCHEDULE OF DECONSOLIDATION OF

SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details)	Dec. 29, 2021 USD ($)
Discontinued Operations and Disposal Groups [Abstract]
Fair value of Series D Stock and Common stock	$ 31,000
Carrying amount of non-controlling interest of BIGToken	6,045,000
Previous equity adjustments of non-controlling interest	(12,510,000)
Total consolidations	(6,434,000)
Book basis of investment in BIGToken	4,250,000
Loss on disposal of subsidiary	$ (10,684,000)

SCHEDULE OF ASSET AND LIABILITI

SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Discontinued Operations and Disposal Groups [Abstract]
Revenues		$ 765,000		$ 2,469,000
Cost of revenues		207,000		715,000
Employee related costs		988,000		2,649,000
Marketing and selling expenses		372,000		861,000
Platform costs		78,000		245,000
Depreciation and amortization		101,000		412,000
General and administrative expenses		1,078,000		3,483,000
Total cost and expenses		2,824,000		8,365,000
Loss from operations		(2,059,000)		(5,896,000)
Deemed dividend on preferred stock				(5,859,000)
Total other expense				(5,859,000)
Loss from discontinued operations before income tax expense		(2,059,000)		(11,755,000)
Income tax expense
Loss from discontinued operations		$ (2,059,000)		$ (11,755,000)

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details Narrative) - USD ($) $ in Millions			3 Months Ended
	Dec. 29, 2021	Sep. 27, 2021	Mar. 31, 2021	Sep. 30, 2022	Dec. 31, 2021	Feb. 04, 2021
Issuance of acquisition shares description	BIGToken (formerly FPVD) completed a merger transaction with BritePool, Inc. (“BritePool”) (the “Merger”) resulting in the Company’s ownership in BIGToken being reduced from 66% to approximately 4.99%.
Shares issued for cash, shares	220,000
Loss on sale of equity investments	$ 10.7
Common Stock [Member]
Conversion of stock shares converted	13,692,304,136
Issued and outstanding of common stock	4.99%
Shares issued for cash, shares			53,616
Force Protection Video Equipment Corp [Member] | Minimum [Member]
Equity method investment, ownership percentage						88.90%
Series A Preferred Stock [Member]
Preferred stock, shares issued				36,462,417	36,462,417
Preferred stock, shares outstanding		25,160,504		36,462,417	36,462,417
Shares issued for cash, shares		36,462,417
Series D Convertible Preferred Stock [Member]
Conversion of stock shares converted	22,162
Exchange Agreement [Member] | Force Protection Video Equipment Corp [Member] | Maximum [Member]
Equity method investment, ownership percentage						100%
Force Protection Video Equipment Corp [Member] | Exchange Agreement [Member]
Business acquisition percentage						100%
Common stock, shares issued						149,562,566,534
Common stock, shares outstanding						149,562,566,534
Force Protection Video Equipment Corp [Member] | Exchange Agreement [Member] | Series A Preferred Stock [Member]
Preferred stock, shares issued						5,000,000
Preferred stock, shares outstanding						5,000,000
Brite Pool Inc [Member]
Stock issued during period shares acquisitions	183,445,351,631
Exchanged number of shares for common stock	149,562,566,534
Brite Pool Inc [Member] | Series D Convertible Preferred Stock [Member]
Exchanged number of shares for common stock	242,078

NOTES RECEIVABLE (Details Narra

NOTES RECEIVABLE (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Oct. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Receivables [Abstract]
Repurchase price	$ 8,000,000	$ 900,000
Price paid for units	7,000,000
Additional repurchase price	1,000,000
Deferred payments	1,000,000
Implied discount	$ 107,000
Notes receivable amortized period	amortized over 3 years
Payment for one time offer to settlement		900,000
Notes receivable				$ 935,000

SCHEDULE OF MARKETABLE SECURITI

SCHEDULE OF MARKETABLE SECURITIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Balances at beginning of year			$ 15,617,000
Transfers
Additions			15,943,000
Sales proceeds			(3,385,000)
Realized loss	$ (286,000)	$ 286,000	(6,521,000)	$ 1,095,000
Current period change in fair value			(533,000)
Balances at ending of year	21,121,000		21,121,000
Convertible Debentures [Member]
Balances at beginning of year			4,187,000
Transfers			(325,000)
Additions			937,000
Sales proceeds
Realized loss
Current period change in fair value			4,429,000
Balances at ending of year	9,228,000		9,228,000
Common Stock [Member]
Balances at beginning of year			10,735,000
Transfers			356,000
Additions			14,006,000
Sales proceeds			(3,385,000)
Realized loss			(6,521,000)
Current period change in fair value			(3,462,000)
Balances at ending of year	11,729,000		11,729,000
Preferred Stock [Member]
Balances at beginning of year			599,000
Transfers			(31,000)
Additions			1,000,000
Sales proceeds
Realized loss
Current period change in fair value			(1,467,000)
Balances at ending of year	101,000		101,000
Warrant [Member]
Balances at beginning of year			96,000
Transfers
Additions
Sales proceeds
Realized loss
Current period change in fair value			(33,000)
Balances at ending of year	$ 63,000		$ 63,000

MARKETABLE SECURITIES (Details

MARKETABLE SECURITIES (Details Narrative) - USD ($)		9 Months Ended
	Feb. 15, 2022	Sep. 30, 2022	Dec. 31, 2021
Product Information [Line Items]
Marketable securities		$ 21,121,000	$ 15,617,000
Marketable securities, current		2,918,000	15,617,000
Marketable securities, noncurrent		18,203,000
Proceed from sale and maturity of marketable securities		3,400,000
Sale of securities		9,900,000
Gain on marketable securities		6,500,000
Big Token Inc [Member] | Safe Agreement [Member]
Product Information [Line Items]
Proceeds for payment from Investments	$ 1,000,000
Investments		0
Customer Concentration Risk [Member] | Marketable Securities [Member] | Top Marketable Security [Member]
Product Information [Line Items]
Marketable securities		$ 2,300,000
Concentration Risk, Percentage		11%
Customer Concentration Risk [Member] | Marketable Securities [Member] | Top Five Marketable Security [Member]
Product Information [Line Items]
Marketable securities		$ 8,700,000
Concentration Risk, Percentage		41%
Customer Concentration Risk [Member] | Marketable Securities [Member] | Top Ten Marketable Security [Member]
Product Information [Line Items]
Marketable securities		$ 13,000,000
Concentration Risk, Percentage		61%

SCHEDULE OF DESIGNATED ASSETS (

SCHEDULE OF DESIGNATED ASSETS (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Designated Assets For Return Of Capital
Cash		$ 686,000
Marketable equity securities	221,000	3,239,000
Total	$ 221,000	$ 3,925,000

SCHEDULE OF MARKETABLE EQUITY S

SCHEDULE OF MARKETABLE EQUITY SECURITY ACTIVITY IN DESIGNATED ASSETS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Balances at beginning of year			$ 15,617,000
Sales proceeds				$ (429,000)
Realized loss	$ (286,000)	$ 286,000	(6,521,000)	$ 1,095,000
Balances at ending of year	21,121,000		21,121,000
Designated Assets [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Balances at beginning of year			3,239,000
Sales proceeds			(505,000)
Realized loss			(1,803,000)
Change in fair value of designated assets			(710,000)
Balances at ending of year	$ 221,000		$ 221,000

DESIGNATED ASSETS FOR RETURN _3

DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Sale of marketable securities	$ 3,400,000
Marketable Securities	3,385,000	$ 7,144,000
Designated Assets [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Sale of marketable securities	500,000
Marketable Securities	2,300,000
Loss on marketable securities	$ 1,800,000

SALES AND PURCHASE OF ACCOUNT_2

SALES AND PURCHASE OF ACCOUNTS RECEIVABLE AND SHORT TERM FINANCINGS (Details Narrative) - USD ($)	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Borrowings outstanding		$ 0	$ 633,000
Other current liabilities		844,000	763,000
PIPE Technologies [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Right to future subscription revenues			625,000
Subscription revenues			$ 576,000
Third Party Lenders Agreement [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Secured debt	$ 4,170,000
Proceeds from issuance of secured debt	$ 3,044,000
CVR Agreement [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Other current liabilities		613,000
CVR Agreement [Member] | Institutional Investor [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Purchase price		$ 405,000
Debt instrument, description		the investor received (i) the right to receive the net proceeds upon the sale of certain marketable securities held by the Company with a guaranteed minimum return of 120% of such Purchase Price or $486,000 and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the sales of such securities.
Debentures [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Converted debt				$ 788,000

SCHEDULE OF OID CONVERTIBLE DEB

SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details) - USD ($)	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Short-Term Debt [Line Items]
Principal	$ 1,267,000
Debt discount	(70,000)
Net book value	1,197,000
Principal	1,146,000	$ 1,267,000
Debt discount	(52,000)	(70,000)
Net book value	1,094,000	1,197,000
Principal	1,146,000	1,267,000
Debt discount	(52,000)	(70,000)
Net book value	1,094,000	1,197,000
Issuance During the Year [Member]
Short-Term Debt [Line Items]
Principal		1,267,000	$ 1,267,000
Debt discount		(86,000)	(103,000)
Net book value		1,181,000	1,164,000
Principal			1,267,000
Debt discount			(86,000)
Net book value			1,181,000
Principal			1,267,000
Debt discount			(86,000)
Net book value			1,181,000
Amortization [Member]
Short-Term Debt [Line Items]
Principal
Debt discount	16,000	17,000
Net book value	16,000	17,000
Principal
Debt discount	18,000	16,000	17,000
Net book value	18,000	16,000	17,000
Principal
Debt discount	18,000	16,000	17,000
Net book value	18,000	$ 16,000	$ 17,000
Principal Adjustments [Member]
Short-Term Debt [Line Items]
Principal	74,000
Debt discount
Net book value	74,000
Principal	74,000
Debt discount
Net book value	74,000
Repayments [Member]
Short-Term Debt [Line Items]
Principal	(195,000)
Debt discount
Net book value	(195,000)
Principal	(195,000)
Debt discount
Net book value	$ (195,000)

OID CONVERTIBLE NOTE(S) PAYAB_3

OID CONVERTIBLE NOTE(S) PAYABLE (Details Narrative) - USD ($)			1 Months Ended	9 Months Ended
	Jul. 01, 2022	Jun. 30, 2020	Jun. 30, 2020	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021
Short-Term Debt [Line Items]
Warrant to purchase common stock, shares				6,309,186
Warrants exercise price per share				$ 3.17
Warrants issuance					$ 4,774,000
Holders [Member]
Short-Term Debt [Line Items]
Principal amount	$ 1,197,000	$ 1,197,000	$ 1,197,000
Debt instrument, description	(i) extend the maturity date of the Debentures until June 30, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures.
Securities Purchase Agreement [Member] | Placement Agent [Member]
Short-Term Debt [Line Items]
Proceeds from warrants percentage				8%
OID Convertible Debentures [Member]
Short-Term Debt [Line Items]
Principal amount		16,101,000	16,101,000
Debt discount		$ 14,169,000	$ 14,169,000
Original issue discount percentage		12%	12%
Warrant to purchase common stock, shares		6,440,561	6,440,561
Proceeds from warrants exercise		$ 13,000,000	$ 13,000,000
Outstanding loan		1,169,000	$ 1,169,000
Proceeds from notes payable		$ 9,100,000
Interest rate						12%
Maturity date, description				The Debentures had an original maturity date of December 31, 2021 but were extended three times and now mature on June 30, 2023
Debt instrument, convertible, conversion price		$ 2.69	$ 2.69
Warrant or right, reason for issuance, description			Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company.
Debt instrument, description			Subject to the Company’s compliance with certain conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that the Company (i) sells or reprices any securities (each, a “Redemption Financing”), or (ii) disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures.
Debt instrument, restrictive covenants			The Company is also prohibited from certain activities (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser), including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends.
Warrants exercise price per share		$ 2.50	$ 2.50
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member]
Short-Term Debt [Line Items]
Warrants exercise price per share				$ 3.3625
Warrants issuance				$ 360,000
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member] | Placement Agent [Member]
Short-Term Debt [Line Items]
Warrant to purchase common stock, shares				478,854
Payments of debt issuance costs				$ 1,040,000

SCHEDULE OF SENIOR SECURED REVO

SCHEDULE OF SENIOR SECURED REVOLVING CREDIT FACILITY RELATED ACTIVITY (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Line of Credit Facility [Line Items]
Loan proceeds		$ 4,686,000
Amortization of debt discount		154,000	$ 799,000
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of credit, principal amount
Line of credit, net amount
Loan proceeds	6,128,000
Original issue debt discount	(750,000)
Repayments of line of credit	(4,000)
Amortization of debt discount	104,000
Line of credit, principal amount	6,124,000	6,124,000
Debt discount	(646,000)
Line of credit, net amount	$ 5,478,000	$ 5,478,000

SENIOR SECURED REVOLVING CRED_3

SENIOR SECURED REVOLVING CREDIT FACILITY (REVOLVING NOTE) (Details Narrative) - USD ($)	Aug. 08, 2022	Jul. 01, 2022	Dec. 29, 2021	Jun. 30, 2020	Nov. 29, 2018	Oct. 27, 2017	Sep. 30, 2022	Jul. 31, 2022	Jun. 30, 2022
Warrant to purchase common stock, shares							6,309,186
Number of shares issued			220,000
Warrant [Member]
Warrant to purchase common stock, shares							203,926	31,872	203,926
Warrant [Member] | Security Agreements [Member]
Number of shares issued				1,313,636	166,667	480,028
Warrant [Member] | Security Agreements [Member] | Tranche One [Member]
Number of shares issued					480,027
Senior Secured Revolving Credit Facility [Member] | Institutional Investor [Member]
Line of credit facility, current borrowing capacity	$ 9,450,000
Line of credit facility, maximum borrowing capacity	$ 5,500,000
Warrant to purchase common stock, shares	2,590,358
Expiration date	Sep. 30, 2023
Credit facility, description	The principal balance of each Revolving Note will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%, and 18% in the event of default. The Revolving Note have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents.
Conversion, description	The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends, fundamental transactions and certain future sales of the Company’s Common Stock.
Number of shares issued	33,000
Senior Secured Revolving Credit Facility [Member] | Lender [Member]
Line of credit facility, maximum borrowing capacity	$ 5,580,000
Line of credit facility, additional borrowing value	4,930,000
Senior Secured Revolving Credit Facility [Member] | Lender [Member] | Maximum [Member]
Line of credit facility, additional borrowing value	3,870,000
Bridge Note [Member]
Debt instrument, face amount		$ 650,000
Debt amount		$ 500,000
Maturity date		Aug. 15, 2022
Bridge Note [Member] | Senior Secured Revolving Credit Facility [Member] | Lender [Member]
Debt instrument, face amount	$ 650,000

COMMON AND PREFERRED STOCK (Det

COMMON AND PREFERRED STOCK (Details Narrative) - USD ($)				1 Months Ended			3 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	Jan. 02, 2022	Dec. 29, 2021	Sep. 27, 2021	Jul. 31, 2022	Jan. 31, 2022	Aug. 31, 2021	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Sep. 20, 2021	Feb. 21, 2021
Class of Stock [Line Items]
Shares issued for cash, shares		220,000
Number of shares exercised												427,667
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right							6,309,186					6,309,186
Warrant to purchase common stock, shares									1,710,078
Common Stock [Member]
Class of Stock [Line Items]
Shares issued for cash, shares										53,616
Number of shares exercised							31,872
Stock issued during warrants exercise								8,401				8,401
Stock issued during warrants exercise value								$ 32,000				$ 32,000
Stock issued during period, shares, conversion of convertible securities									730,616	2,041,551
Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right				31,872			203,926	203,926			203,926	203,926
Stock issued during warrants exercise				100,000				697,574				697,574
Stock issued during warrants exercised on cashless basis								689,173				689,173
Warrant to purchase common stock, shares															4,545,440
Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock authorized							50,000,000					50,000,000
Share Buy-Back Program [Member]
Class of Stock [Line Items]
Number of repurchased shares											0		155,000
Number of repurchased value													$ 793,000
Remaining authorization for future common shares repurchases								$ 9,200,000			$ 9,200,000
At the Market Sales Agreement [Member]
Class of Stock [Line Items]
Sale of stock													53,616
Sale of stock, consideration received on transaction													$ 284,000
Chief Executive Officer [Member] | Equity Compensation Plans [Member]
Class of Stock [Line Items]
Shares issued for cash, shares	100,000
Number of shares withheld to cashless exercise	57,016
Additional shares withheld for tax withholding	16,732
Common stock issued	26,252
Non Executive Employees [Member] | Equity Compensation Plans [Member]
Class of Stock [Line Items]
Number of shares withheld to cashless exercise					161,938
Number of shares exercised					227,667
Non Executive Employees [Member] | Equity Compensation Plans [Member] | Common Stock [Member]
Class of Stock [Line Items]
Shares issued for cash, shares					65,729
Class A common stock [Member]
Class of Stock [Line Items]
Common stock shares authorized							250,000,000					250,000,000
Common stock par value							$ 0.001					$ 0.001
Class A common stock [Member] | Board of Directors [Member]
Class of Stock [Line Items]
Repurchase of common stock						$ 10,000,000
Class B Common Stock [Member]
Class of Stock [Line Items]
Common stock shares authorized							9,000,000					9,000,000
Common stock par value							$ 0.001					$ 0.001
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Shares issued for cash, shares			36,462,417
Preferred stock authorized							36,462,417					36,462,417	36,462,417
Preferred stock par value							$ 0.001					$ 0.001
Dividend description			the Company issued a one-time dividend of 36,462,417 shares of series A preferred stock (“Preferred Stock”) to certain Qualified Recipients (the “Dividend”). The preferred stock entitles the Qualified Recipients with the right to receive the net proceeds from sales of certain marketable securities that the Company received through its Sequire Platform services. See Note 6 – Designated Assets for Return of Capital
Preferred stock, shares outstanding			25,160,504				36,462,417					36,462,417	36,462,417
Warrant to purchase common stock, shares			10,327,645
Conversion of convertible securities			$ 2,486,275
Stock issued during period, shares, conversion of convertible securities			974,268
Series A Preferred Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Preferred stock authorized														36,462,417

SCHEDULE OF STOCK OPTION ACTIVI

SCHEDULE OF STOCK OPTION ACTIVITY (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Jan. 06, 2022	Jan. 03, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option Shares, Outstanding Beginning balance | shares	1,334,287
Weighted Average Exercise Price, Outstanding Beginning balance	$ 3.02
Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance	4 years 1 month 6 days	2 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding Beginning balance | $
Option of Shares, Granted | shares	718,132
Weighted Average Execise Price, Granted	$ 4.27
Weighted Average Remaining Contractual Term (Years), Granted	5 years 2 months 12 days
Aggregate Intrinsic Value, Granted
Option of Shares, Exercised | shares	(427,667)
Weighted Average Execise Price, Exercised	$ 3.21
Aggregate Intrinsic Value, Exercised | $
Option of Shares, Forfeited | shares	(110,000)
Weighted Average Execise Price, Forfeited	$ 3.42
Options of Shares, Outstanding Ending balance | shares	1,514,752	1,334,287
Weighted Average Execise Price, Outstanding Ending balance	$ 3.53	$ 3.02
Aggregate Intrinsic Value, Outstanding Ending balance | $
Options of Shares, Exercisable Ending balance | shares	756,486
Weighted Average Execise Price, Exercisable Ending balance	$ 3.30
Weighted Average Remaining Contractual Term (Years), Exercisable Ending balance	3 years 10 months 24 days
Aggregate Intrinsic Value, Exercisable Ending balance | $
Share-Based Payment Arrangement, Option [Member] | Measurement Input, Expected Term [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input			4.4	5
Share-Based Payment Arrangement, Option [Member] | Measurement Input, Risk Free Interest Rate [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input			1.55	1.55
Share-Based Payment Arrangement, Option [Member] | Measurement Input, Option Volatility [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input			90	90
Share-Based Payment Arrangement, Option [Member] | Measurement Input, Expected Dividend Rate [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input
Stock Option One [Member] | Measurement Input, Expected Term [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input			3.4
Stock Option One [Member] | Measurement Input, Risk Free Interest Rate [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input			1.60
Stock Option One [Member] | Measurement Input, Option Volatility [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input			90
Stock Option One [Member] | Measurement Input, Expected Dividend Rate [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity Securities, FV-NI, Measurement Input

SUMMARY OF OUTSTANDING AND EXER

SUMMARY OF OUTSTANDING AND EXERCISABLE WARRANTS (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Warrant shares	4,157,692
Weighted average exercise price	$ 3.17
Weighted average exercise price	4 years 1 month 6 days	2 years 4 months 24 days
Warrant One [Member]
Class of Warrant or Right [Line Items]
Warrant shares	1,375,455
Weighted average exercise price	$ 2.50
Weighted average exercise price	1 year
Warrant Two [Member]
Class of Warrant or Right [Line Items]
Warrant shares	1,160,056
Weighted average exercise price	$ 3
Weighted average exercise price	1 year
Warrant Three [Member]
Class of Warrant or Right [Line Items]
Warrant shares	478,854
Weighted average exercise price	$ 3.36
Weighted average exercise price	1 month 6 days
Warrant Four [Member]
Class of Warrant or Right [Line Items]
Warrant shares	1,047,778
Weighted average exercise price	$ 4
Weighted average exercise price	0 years
Warrant Five [Member]
Class of Warrant or Right [Line Items]
Warrant shares	17,749
Weighted average exercise price	$ 4.50
Weighted average exercise price	1 year 10 months 24 days
Warrant Six [Member]
Class of Warrant or Right [Line Items]
Warrant shares	77,800
Weighted average exercise price	$ 5
Weighted average exercise price	1 year 6 months
Warrant [Member]
Class of Warrant or Right [Line Items]
Weighted average exercise price	7 months 6 days

EQUITY COMPENSATION PLANS AND_3

EQUITY COMPENSATION PLANS AND WARRANTS (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

Jan. 06, 2022

Jan. 03, 2022

Jan. 02, 2022

Dec. 29, 2021

Feb. 21, 2021

Jun. 30, 2020

Nov. 29, 2018

Oct. 27, 2017

Jul. 31, 2022

Jan. 31, 2022

Sep. 30, 2022

Jun. 30, 2022

Sep. 30, 2021

Mar. 31, 2021

Sep. 30, 2022

Sep. 30, 2021

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

220,000

Number of shares exercised

427,667

Shares issued upon exercise of warrants

6,309,186

6,309,186

Stock-based compensation

$ 281,000

$ (231,000)

$ 757,000

Stock-based compensation expenses

$ 253,000

908,000

$ 757,000

Share based compensation benefit

1,139,000

Cumulative adjustment to reverse stock based compensation

1,139,000

Unrecognized compensation expenses

$ 1,835,000

$ 1,835,000

Weighted average remaining contractual term (years)

2 years 3 months 18 days

Warrant expired shares

76,190

5,177,327

Warrant modification expense

$ 1,788,000

Number of common stock and warrants shares

1,710,078

1,710,078

Class of warrant or right, exercise price of warrants or rights

$ 3.17

$ 3.17

Proceeds from issuance of warrants

$ 4,774,000

Fair value of warrants

$ 1,788,000

Warrants cancelled during the period

349,197

Common Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

53,616

Number of shares exercised

31,872

Stock issued during warrants exercise

8,401

8,401

Stock issued during warrants exercise value

$ 32,000

$ 32,000

Warrant modification expense

Common Stock [Member] | Security Agreements [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

1,363,636

166,667

530,028

Common Stock [Member] | Security Agreements [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

1,313,636

Common Stock [Member] | Security Agreements [Member] | Share-Based Payment Arrangement, Tranche Two [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

166,667

Common Stock [Member] | Security Agreements [Member] | Share-Based Payment Arrangement, Tranche Three [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

480,027

Common Stock [Member] | Security Agreements [Member] | Share Based Compensation Award Tranche Four [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

480,028

Warrant [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Shares issued upon exercise of warrants

31,872

203,926

203,926

203,926

Stock issued during warrants exercise

100,000

697,574

697,574

Stock issued during warrants exercised on cashless basis

689,173

689,173

Number of common stock and warrants shares

4,545,440

Proceeds from issuance of warrants

$ 11,022,000

Proceeds from warrant exercises

$ 15,953,000

Warrant [Member] | Security Agreements [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

1,313,636

166,667

480,028

New Warrant [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of common stock and warrants shares

4,545,440

Class of warrant or right, exercise price of warrants or rights

$ 7.50

Warrants and rights outstanding, maturity date

Jan. 31, 2022

Share price

$ 0.125

Proceeds from issuance of warrants

$ 568,000

Proceeds from warrant exercises

11,363,000

Solicitation fees

909,000

Fair value of warrants

$ 7,737,000

Implied volatility

96%

Risk free equivalent yield

11%

Stock price per share

$ 5.83

Equity Compensation Plans [Member] | Chief Executive Officer [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

100,000

Number of shares withheld to cashless exercise

57,016

Additional shares withheld for tax withholding

16,732

Common stock issued

26,252

Stock option exercise price

$ 4.25

Option vesting period

3 years

Option expire period

7 years

Number of option grant date, value

$ 356,000

Aggregate execise amount

120,000

Equity Compensation Plans [Member] | Nonemployee Directors [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

29,533

Stock option exercise price

$ 4.35

Aggregate execise amount

$ 128,500

Option vesting period

1 year

Option expire period

7 years

Number of option grant date, value

$ 100,000

Equity Compensation Plans [Member] | Non Executive Employees [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares withheld to cashless exercise

161,938

Number of shares exercised

227,667

Equity Compensation Plans [Member] | Non Executive Employees [Member] | Common Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued

65,729

Equity Compensation Plans [Member] | Employee [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Stock option exercise price

$ 4.25

Option vesting period

3 years

Option expire period

7 years

Number of option grant date, value

$ 296,000

Aggregate execise amount

100,000

Equity Compensation Plans [Member] | Employee [Member] | Conditional Grant [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Stock option exercise price

$ 4.25

Option vesting period

3 years

Option expire period

5 years

Number of option grant date, value

$ 55,000

Aggregate execise amount

20,000

Equity Compensation Plans [Member] | Chief Financial Officer [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Stock option exercise price

$ 4.25

Option vesting period

3 years

Option expire period

7 years

Number of option grant date, value

$ 296,000

Aggregate execise amount

100,000

Class A common stock [Member] | Equity Compensation Plans [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of common stock reserved for issuance

228,000

228,000

Class A common stock [Member] | Equity Compensation Plans [Member] | Non Executive Employees [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Stock option exercise price

$ 4.25

Option vesting period

3 years

Option expire period

5 years

Number of option grant date, value

$ 1,038,000

Aggregate execise amount

380,000

SCHEDULE OF REVENUE BY REVENUE

SCHEDULE OF REVENUE BY REVENUE STREAM (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 5,309,000	$ 6,888,000	$ 20,530,000	$ 18,963,000
Sequire Platform Revenue [Member]
Disaggregation of Revenue [Line Items]
Total revenue	5,306,000	6,888,000	19,225,000	17,879,000
Conference Revenue [Member]
Disaggregation of Revenue [Line Items]
Total revenue	3,000		1,305,000	390,000
Other Revenues [Member]
Disaggregation of Revenue [Line Items]
Total revenue				$ 694,000

SCHEDULE OF REVENUE RECOGNIZED

SCHEDULE OF REVENUE RECOGNIZED IN EXCHANGE FOR CUSTOMER SECURITIES AND CASH (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 5,309,000	$ 6,888,000	$ 20,530,000	$ 18,963,000
Customer Securities [Member]
Disaggregation of Revenue [Line Items]
Total revenue	4,589,000	6,409,000	16,663,000	15,035,000
Revenue Cash [Member]
Disaggregation of Revenue [Line Items]
Total revenue	$ 720,000	$ 479,000	$ 3,867,000	$ 3,928,000

REVENUE (Details Narrative)

REVENUE (Details Narrative)	9 Months Ended
	Sep. 30, 2022 Segments Integer
Revenue from Contract with Customer [Abstract]
Numebr of operating segment	1
Numebr of reportable segment	1
Numebr of reportable unit | Integer	1

SCHEDULE OF ASSETS MEASURED AT

SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 21,841,000	$ 20,386,000
Liabilities, Fair Value Disclosure	1,045,000	3,925,000
Series A Preferred Stock [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	1,045,000	3,925,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	2,768,000	6,393,000
Liabilities, Fair Value Disclosure
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Series A Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	9,599,000	6,114,000
Liabilities, Fair Value Disclosure	1,045,000	3,925,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Series A Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	1,045,000	3,925,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	9,474,000	7,879,000
Liabilities, Fair Value Disclosure
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Series A Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure
Fair Value, Recurring [Member] | Marketable Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	21,121,000	15,617,000
Fair Value, Recurring [Member] | Marketable Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	2,164,000	6,134,000
Fair Value, Recurring [Member] | Marketable Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	9,483,000	2,448,000
Fair Value, Recurring [Member] | Marketable Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	9,474,000	7,035,000
Fair Value, Recurring [Member] | Designated assets marketable securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	221,000	3,925,000
Fair Value, Recurring [Member] | Designated assets marketable securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	105,000	259,000
Fair Value, Recurring [Member] | Designated assets marketable securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	116,000	3,666,000
Fair Value, Recurring [Member] | Designated assets marketable securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure
Fair Value, Recurring [Member] | Contracts Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	499,000	844,000
Fair Value, Recurring [Member] | Contracts Assets [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	499,000
Fair Value, Recurring [Member] | Contracts Assets [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure
Fair Value, Recurring [Member] | Contracts Assets [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure		$ 844,000

SCHEDULE OF FAIR VALUE AT ASSET

SCHEDULE OF FAIR VALUE AT ASSETS (Details) - Fair Value, Inputs, Level 3 [Member]	9 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance as of December 31, 2021	$ 7,035,000
Transfers	(2,455,000)
Additions	2,419,000
Sales proceeds	(156,000)
Realized loss	(60,000)
Current period change in fair value	2,691,000
Balance as of September 30, 2022	9,474,000
Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance as of December 31, 2021	2,153,000
Transfers	(2,099,000)
Additions	481,000
Sales proceeds	(156,000)
Realized loss	(60,000)
Current period change in fair value	(238,000)
Balance as of September 30, 2022	81,000
Convertible Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance as of December 31, 2021	4,187,000
Transfers	(325,000)
Additions	938,000
Sales proceeds
Realized loss
Current period change in fair value	4,429,000
Balance as of September 30, 2022	9,229,000
Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance as of December 31, 2021	599,000
Transfers	(31,000)
Additions	1,000,000
Sales proceeds
Realized loss
Current period change in fair value	(1,467,000)
Balance as of September 30, 2022	101,000
Warrant [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance as of December 31, 2021	96,000
Transfers
Additions
Sales proceeds
Realized loss
Current period change in fair value	(33,000)
Balance as of September 30, 2022	$ 63,000

SCHEDULE OF FAIR VALUE ASSETS S

SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details) - Fair Value, Inputs, Level 3 [Member]	9 Months Ended
	Sep. 30, 2022
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Maturity [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range, maturity	0 months
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Maturity [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range, maturity	28 months
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	64
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	224
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	2.27
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	2.96
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	0
Common Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	0
Common Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	32.3
Convertible Preferred Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	0
Convertible Preferred Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	54
Convertible Debt Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Maturity [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range, maturity	0 months
Convertible Debt Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Maturity [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range, maturity	28 months
Convertible Debt Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	17.3

FAIR VALUE OF FINANCIAL INSTR_3

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Contracts receivable, value	$ 499,000	$ 844,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	1 Months Ended
	May 31, 2022 USD ($)
Related Party Transactions [Abstract]
Related party transaction, amount	$ 497,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)								3 Months Ended	9 Months Ended
	Jul. 17, 2023	Mar. 03, 2023	Feb. 03, 2023	Dec. 29, 2021	Jun. 30, 2020	Nov. 29, 2018	Oct. 27, 2017	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Subsequent Event [Line Items]
Cash									$ 116,000		$ 1,348,000
Number of shares issued				220,000
Cash payments										$ 3,004,000
Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued								53,616
Subsequent Event [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share			$ 1
Number of shares issued for services	500,000
Subsequent Event [Member] | LD Micro Inc [Member]
Subsequent Event [Line Items]
Business acquisitions for consideration		$ 8,300,000
Cash payments		$ 4,000,000
Number of common stock acquired		59,763
Common stock par value		$ 0.001
Business acquisition description		4,300,000
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Common stock conversion basis description			In accordance with applicable Nasdaq listing rules, the Company plans to obtain stockholder approval to issue the shares of Common Stock underlying the Series B Preferred Stock so that it may issue shares of Common Stock to the Seller in excess of 1,313,127 shares of Common Stock, the amount of shares equal to 4.99% of the issued and outstanding Common Stock on the Closing Date (“Stockholder Approval”). Within thirty (30) days, but not earlier than fifteen (15) business days after Stockholder Approval is obtained, the Seller will prepare and deliver to the Company a written determination, in the Seller’s sole and absolute discretion, of an amount equal to or less than $2,000,000 to be paid to the Company, if any (such amount to be paid to the Company, the “Deferred Payment” and such amount that will not be paid to the Company, the “Uncollected Deferred Payment”). Within five (5) business days of the delivery of such written determination, subject and upon receipt of the Deferred Payment, the Company and the Seller will instruct the Escrow Agent to release to the Company such number of Escrow Shares based upon the shares of Common Stock underlying the Series B Preferred Stock multiplied by the quotient of (i) the outstanding Uncollected Deferred Payment divided by (ii) $2,000,000. The balance of the Escrow Shares will then be released to the Seller (the “Post-Closing Adjustment”). In the event Stockholder Approval is not received on or prior to the eighteen (18) month anniversary of the Closing, the Deferred Payment will lapse and the Escrow Shares will all be released to the Company
Subsequent Event [Member] | Series B Preferred Stock [Member]
Subsequent Event [Line Items]
Common stock conversion basis description			Pursuant to the terms of the APA, at the closing of the Acquisition (the “Closing”), in exchange for the Purchased Assets, the Company issued and delivered to Seller (i) 1,313,127 shares of the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”), and (ii) 63,743 shares of the Company’s newly designated class of Series B Non-Voting Convertible Preferred Stock (the “Series B Preferred Stock”) convertible, subject to the receipt of Stockholder Approval (as defined below), into an aggregate of 3,059,664 shares of Common Stock (collectively, the “Upfront Shares”). In addition to the Upfront Shares, the Company delivered into escrow 54,908 shares of Series B Preferred Stock convertible, subject to receipt of Stockholder Approval and the Deferred Payment (as defined below), into 2,635,591 shares of Common Stock (the “Escrow Shares,” together with the Upfront Shares, the “Acquisition Shares”).
Asset Purchase Agreement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Cash			$ 1,000,000
Security Agreements [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued					1,363,636	166,667	530,028
Security Agreements [Member] | Common Stock [Member] | Tranche One [Member]
Subsequent Event [Line Items]
Number of shares issued						530,027